[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 180
6. Wysluch A, Hölzle F, Maurer P: [Giant ameloblastoma of the jaw]. HNO; 2009 Nov;57(11):1193-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Giant ameloblastoma of the jaw].
  • As demonstrated by the case of a 71-year-old patient with giant ameloblastoma of the upper jaw, early resection is recommended.
  • [MeSH-major] Ameloblastoma / diagnosis. Mandibular Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Dec;104(6):e17-24 [17942338.001]
  • [Cites] J Craniomaxillofac Surg. 1993 Dec;21(8):351-5 [8113429.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Oct;104(4):478-85 [17524681.001]
  • [Cites] Mund Kiefer Gesichtschir. 2006 Jan;10(1):1-2 [16328532.001]
  • [Cites] Radiographics. 1999 Sep-Oct;19(5):1107-24 [10489168.001]
  • [Cites] Am J Otolaryngol. 2002 Jan-Feb;23 (1):44-8 [11791248.001]
  • [Cites] Plast Reconstr Surg. 1972 Sep;50(3):242-8 [4115148.001]
  • [Cites] Niger Postgrad Med J. 2008 Mar;15(1):1-5 [18408774.001]
  • [Cites] Int J Oral Maxillofac Surg. 2007 Apr;36(4):283-8 [17222535.001]
  • (PMID = 19727626.001).
  • [ISSN] 1433-0458
  • [Journal-full-title] HNO
  • [ISO-abbreviation] HNO
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


7. Zhang B, Zhang J, Xu ZY, Xie HL: Expression of RECK and matrix metalloproteinase-2 in ameloblastoma. BMC Cancer; 2009;9:427

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of RECK and matrix metalloproteinase-2 in ameloblastoma.
  • BACKGROUND: Ameloblastoma is a frequent odontogenic benign tumor characterized by local invasiveness, high risk of recurrence and occasional metastasis and malignant transformation.
  • The aim of this study was to characterize the relationship between RECK and MMP-2 expression and the clinical manifestation of ameloblastoma.
  • METHODS: Immunohistochemistry and reverse transcription-polymerase chain reaction (RT-PCR) were employed to detect the protein and mRNA expression of RECK and MMP-2 in keratocystic odontogenic tumor (KCOT), ameloblastoma and ameloblastic carcinoma.
  • RESULTS: RECK protein expression was significantly reduced in KCOT (87.5%), ameloblastoma (56.5%) and ameloblastic carcinoma (0%) (P < 0.01), and was significantly lower in recurrent ameloblastoma compared with primary ameloblastoma (P < 0.01), but did not differ by histological type of ameloblastoma.
  • MMP-2 protein expression was significantly higher in ameloblastoma and ameloblastic carcinoma compared with KCOT (P < 0.01).
  • RECK mRNA expression was significantly lower in ameloblastoma than in KCOT (P < 0.01), lower in recurrent ameloblastoma than in primary ameloblastoma, and was negative in ameloblastic carcinoma.
  • MMP-2 mRNA expression was significantly higher in ameloblastoma compared with KCOT (P < 0.01), but was no different in recurrent ameloblastoma versus primary ameloblastoma.
  • RECK protein expression was negatively associated with MMP-2 protein expression in ameloblastoma (r = -0.431, P < 0.01).
  • CONCLUSION: Low or no RECK expression and increased MMP-2 expression may be associated with negative clinical findings in ameloblastoma.
  • RECK may participate in the invasion, recurrence and malignant transformation of ameloblastoma by regulating MMP-2 at the post-transcriptional level.
  • [MeSH-major] Ameloblastoma / metabolism. Jaw Neoplasms / metabolism. Matrix Metalloproteinase 2 / biosynthesis. Membrane Glycoproteins / biosynthesis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cell. 2001 Dec 14;107(6):789-800 [11747814.001]
  • [Cites] J Oral Pathol Med. 2009 Oct;38(9):731-6 [19473446.001]
  • [Cites] Clin Cancer Res. 2003 May;9(5):1779-84 [12738734.001]
  • [Cites] Histopathology. 2004 Jul;45(1):65-72 [15228445.001]
  • [Cites] Clin Cancer Res. 2004 Aug 15;10(16):5572-9 [15328199.001]
  • [Cites] J Oral Pathol Med. 2006 Jul;35(6):345-51 [16762015.001]
  • [Cites] Endocr Relat Cancer. 2006 Dec;13(4):1173-83 [17158762.001]
  • [Cites] Int J Colorectal Dis. 2007 Feb;22(2):127-36 [16896992.001]
  • [Cites] Int J Oncol. 2007 Feb;30(2):325-32 [17203213.001]
  • [Cites] Eur J Cancer. 2007 Mar;43(4):799-808 [17236757.001]
  • [Cites] J Gastroenterol. 2007 Feb;42(2):120-8 [17351800.001]
  • [Cites] Biochem Biophys Res Commun. 2007 Apr 20;355(4):937-43 [17328864.001]
  • [Cites] J Orthop Res. 2007 May;25(5):696-702 [17262820.001]
  • [Cites] Pathology. 2007 Oct;39(5):486-90 [17886098.001]
  • [Cites] Am J Clin Oncol. 2007 Dec;30(6):645-8 [18091060.001]
  • [Cites] Ann Acad Med Singapore. 2008 Jan;37(1):32-9 [18265895.001]
  • [Cites] BMC Cancer. 2008;8:182 [18588710.001]
  • [Cites] J Neurooncol. 2008 Sep;89(2):141-50 [18493720.001]
  • [Cites] Oral Oncol. 2009 Aug;45(8):706-11 [19147397.001]
  • [Cites] J Oral Pathol Med. 2003 Feb;32(2):114-20 [12542835.001]
  • (PMID = 19995435.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / GPI-Linked Proteins; 0 / Membrane Glycoproteins; 0 / RECK protein, human; 0 / RNA, Messenger; EC 3.4.24.24 / Matrix Metalloproteinase 2
  • [Other-IDs] NLM/ PMC2794878
  •  go-up   go-down


8. Maria A, Sharma Y: Granular cell - Peripheral ameloblastoma: a rare variant. J Maxillofac Oral Surg; 2009 Sep;8(3):294-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Granular cell - Peripheral ameloblastoma: a rare variant.
  • Ameloblastoma is an epithelial odontogenic tumour of the jaw and exhibits diverse microscopic patterns which occurs either singly or in combination with other patterns.
  • Peripheral ameloblastoma is a rare odontogenic soft tissue tumor, derived from epithelial and/or mesenchymal elements being part of the tooth-forming apparatus.
  • The lesions responsible for approximately 1% to 5% of all cases of ameloblastoma affecting alveolar mucosa and gingiva occurring mainly, in the middle age.
  • This article describes a case of peripheral ameloblastoma affecting a 35-year-old female.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Oral Maxillofac Surg. 1996 Jun;34(3):240-2 [8818258.001]
  • [Cites] J Periodontol. 2000 Jul;71(7):1174-6 [10960026.001]
  • [Cites] J Oral Maxillofac Surg. 2000 Oct;58(10):1150-4 [11021711.001]
  • [Cites] J Oral Maxillofac Surg. 2001 Jul;59(7):811-5 [11429748.001]
  • [Cites] Oral Maxillofac Surg Clin North Am. 2004 Aug;16(3):309-22 [18088733.001]
  • [Cites] Int J Oral Maxillofac Surg. 1992 Feb;21(1):40-4 [1569364.001]
  • [Cites] Int J Oral Maxillofac Surg. 1989 Jun;18(3):140-1 [2474619.001]
  • [Cites] J Oral Maxillofac Surg. 1989 Dec;47(12):1248-55 [2479730.001]
  • [Cites] J Oral Maxillofac Surg. 1987 Sep;45(9):800-4 [3476703.001]
  • [Cites] J Oral Maxillofac Surg. 1994 Feb;52(2):192-7 [8295058.001]
  • [Cites] J Periodontol. 1995 Dec;66(12):1065-8 [8683419.001]
  • (PMID = 23139530.001).
  • [ISSN] 0972-8279
  • [Journal-full-title] Journal of maxillofacial and oral surgery
  • [ISO-abbreviation] J Maxillofac Oral Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3454237
  • [Keywords] NOTNLM ; Granular cell ameloblastoma / Peripheral ameloblastoma
  •  go-up   go-down


9. Senra GS, Pereira AC, Murilo dos Santos L, Carvalho YR, Brandão AA: Malignant ameloblastoma metastasis to the lung: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Feb;105(2):e42-6
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant ameloblastoma metastasis to the lung: a case report.
  • Ameloblastoma is an odontogenic tumor, usually benign, which rarely metastasizes to distant organs.
  • The case of a 27-year-old white woman is described, who presented a metastatic pulmonary ameloblastoma 7 years after the removal of a mandibular ameloblastoma.
  • Clinical and CT investigation confirmed no ameloblastoma recurrence in the jaw and no other primary tumor.
  • The diagnosis of metastatic ameloblastoma was confirmed by microscopic evaluation of the pulmonary nodule.
  • [MeSH-major] Ameloblastoma / secondary. Lung Neoplasms / secondary. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18230377.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


10. Kitkumthorn N, Mutirangura A: LINE-1 methylation difference between ameloblastoma and keratocystic odontogenic tumor. Oral Dis; 2010 Apr;16(3):286-91

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] LINE-1 methylation difference between ameloblastoma and keratocystic odontogenic tumor.
  • Keratocystic odontogenic tumor (KCOT) and ameloblastoma are different tumors but posses the same tissue in origin.
  • Here, we investigated long interspersed nuclear element-1 (LINE-1 or L1) methylation status between ameloblastoma and KCOT.
  • MATERIALS AND METHODS: We studied the methylation levels of the long interspersed nucleotide element-1 (LINE-1) in ameloblastoma and KCOT.
  • After collecting ameloblastoma cells and epithelium lining cells of KCOT by laser capture microdissection from paraffin embedded tissue, combined bisulfite restriction analysis of LINE-1 (COBRALINE-1) was performed to measure LINE-1 methylation levels.
  • RESULTS: The LINE-1 methylation level in KCOT (53.16 +/- 12.03%) was higher than that in ameloblastoma (36.90 +/- 16.52%), with a statistical significance of P = 0.001.
  • CONCLUSION: We found LINE-1 hypomethylation levels between ameloblastoma and KCOT are different.
  • [MeSH-major] Cell Transformation, Neoplastic / genetics. DNA, Neoplasm / analysis. Jaw Neoplasms / genetics. Long Interspersed Nucleotide Elements / genetics. Odontogenic Tumors / genetics
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Ameloblastoma / chemistry. Ameloblastoma / genetics. Child. DNA Methylation. Female. Humans. Keratins. Male. Middle Aged. Promoter Regions, Genetic. Restriction Mapping / methods. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20374511.001).
  • [ISSN] 1601-0825
  • [Journal-full-title] Oral diseases
  • [ISO-abbreviation] Oral Dis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 68238-35-7 / Keratins
  •  go-up   go-down


11. de Souza Andrade ES, Miguel MC, de Almeida Freitas R, Pereira Pinto L, Batista de Souza L: Immunoexpression of integrins in ameloblastoma, adenomatoid odontogenic tumor, and human tooth germs. Int J Surg Pathol; 2008 Jul;16(3):277-85

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunoexpression of integrins in ameloblastoma, adenomatoid odontogenic tumor, and human tooth germs.
  • When these two ameloblastoma types were pooled into a single group, the following significant differences were found: immunoexpression of integrin alpha2beta1 was stronger in ameloblastomas than in AOTs and tooth germs, and the expression of integrin alpha5beta1 was stronger in ameloblastomas than in AOTs.
  • [MeSH-major] Ameloblastoma / metabolism. Biomarkers, Tumor / metabolism. Jaw Neoplasms / metabolism. Receptors, Collagen / metabolism. Tooth Germ / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18573784.001).
  • [ISSN] 1066-8969
  • [Journal-full-title] International journal of surgical pathology
  • [ISO-abbreviation] Int. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Integrin alpha2beta1; 0 / Integrin alpha3beta1; 0 / Integrin alpha5beta1; 0 / Receptors, Collagen
  •  go-up   go-down


12. Iezzi G, Piattelli A, Rubini C, Artese L, Goteri G, Fioroni M, Carinci F: CD10 expression in stromal cells of ameloblastoma variants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Feb;105(2):206-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CD10 expression in stromal cells of ameloblastoma variants.
  • OBJECTIVE: We performed an immunohistochemical study in a series of ameloblastomas with different histology to explore the existence of a correlation between CD10 immunoreactivity in peritumoral stromal cells and the type of ameloblastoma with a high risk of local recurrence.
  • CONCLUSIONS: Our results suggest that CD10 expression might be associated with stromal invasion in ameloblastoma variants with a high risk of recurrences.
  • [MeSH-major] Ameloblastoma / classification. Ameloblastoma / immunology. Jaw Neoplasms / classification. Jaw Neoplasms / immunology. Neprilysin / biosynthesis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17942343.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 3.4.24.11 / Neprilysin
  •  go-up   go-down


13. Sandra F, Hendarmin L, Kukita T, Nakao Y, Nakamura N, Nakamura S: Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone. Oral Oncol; 2005 Jul;41(6):637-44
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone.
  • Ameloblastoma, a tumor located in bone, when neglected, can perforate the bone and, ultimately, spread into the soft tissues.
  • To expand in the bone, ameloblastoma must have a mechanism of resorbing the surrounding bone.
  • In the present study, we found that RANKL and TNFalpha were expressed and secreted by ameloblastoma cells, and was proven to induce osteoclastogenesis.
  • These results suggested that ameloblastoma by secreting RANKL and TNFalpha could induce osteoclastogenesis.
  • [MeSH-major] Ameloblastoma / physiopathology. Bone Resorption / physiopathology. Jaw Neoplasms / physiopathology. Osteoclasts / physiology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15935726.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Carrier Proteins; 0 / Culture Media, Conditioned; 0 / Membrane Glycoproteins; 0 / Neoplasm Proteins; 0 / Proto-Oncogene Proteins; 0 / RANK Ligand; 0 / Receptor Activator of Nuclear Factor-kappa B; 0 / TNFRSF11A protein, human; 0 / TNFSF11 protein, human; 0 / Tumor Necrosis Factor-alpha; EC 2.7.11.1 / AKT1 protein, human; EC 2.7.11.1 / Protein-Serine-Threonine Kinases; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt; EC 2.7.11.24 / JNK Mitogen-Activated Protein Kinases; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 3; EC 2.7.11.24 / p38 Mitogen-Activated Protein Kinases
  •  go-up   go-down


1
Advertisement
4. Ogunsalu C, Daisley H, Henry K, Bedayse S, White K, Jagdeo B, Baldeo S: A new radiological classification for ameloblastoma based on analysis of 19 cases. West Indian Med J; 2006 Dec;55(6):434-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A new radiological classification for ameloblastoma based on analysis of 19 cases.
  • OBJECTIVE: To describe ameloblastoma of the jawbone in young Jamaicans, with special emphasis on radiological findings, and to introduce a radiological classification which could assist in the categorization of these cases according to their biological behaviour and hence their subsequent surgical and medical management.
  • SUBJECTS AND METHODS: The series comprised all the 18 cases of ameloblastoma of the jaw seen in patients under the age of 20 years in the two major hospitals in Jamaica with an oral and maxillofacial surgery department from 1980 to 1995.
  • A case of maxillary ameloblastoma in a 13-year old girl seen in the year 2000 was also included in this study.
  • RESULTS: All 19 patients had primary lesions of ameloblastoma.
  • CONCLUSION: Ameloblastoma in young Jamaicans presented more in the adolescent period and are predominantly unicystic and rare in the maxilla.
  • A new classification for ameloblastoma based solely on radiological presentation is adopted.
  • [MeSH-major] Ameloblastoma / radiography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17691241.001).
  • [ISSN] 0043-3144
  • [Journal-full-title] The West Indian medical journal
  • [ISO-abbreviation] West Indian Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Jamaica
  •  go-up   go-down


15. Odukoya O, Effiom OA: Clinicopathological study of 100 Nigerian cases of ameloblastoma. Niger Postgrad Med J; 2008 Mar;15(1):1-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathological study of 100 Nigerian cases of ameloblastoma.
  • SUMMARY: Clinicopathological analysis and growth rate study of 100 cases of ameloblastoma was undertaken.
  • The estimated monthly growth rate (EMGR) of ameloblastoma was observed to be slower in males although the mean tumour volume recorded in females was lower than males in the series.
  • The biologic aggression of 4 various types of ameloblastoma was predicted using EMGR and average volume of tumour at hospital presentation as predictive markers.
  • Solid multicystic ameloblastoma was observed with the fastest EMGR of 0.81 cm(3)/month.
  • Peripheral ameloblastoma was observed with the slowest EMGR of 0.17 cm(3)/ month.
  • It was concluded that all the 4 types of ameloblastoma observed were clinically distinct and showed varying biologic aggression.
  • It is therefore necessary to distinguish between the various clinical types of ameloblastoma before a clinician proceeds with definitive treatment.
  • [MeSH-major] Ameloblastoma / pathology. Jaw Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18408774.001).
  • [ISSN] 1117-1936
  • [Journal-full-title] The Nigerian postgraduate medical journal
  • [ISO-abbreviation] Niger Postgrad Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Nigeria
  •  go-up   go-down


16. Muvova L, Dilu N, Sokolo M: [The treatment of choice for recurrent ameloblastoma]. Odontostomatol Trop; 2005 Jun;28(110):13-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The treatment of choice for recurrent ameloblastoma].
  • 92 patients with recurring ameloblastoma of jawbones were followed.
  • What implies that the preserving surgery on the recurring ameloblastoma is more beneficial than negative with the two races with more than 80%.
  • The authors thus concluded that this surgical method still keeps its place of choice in the treatment of the repetitions of the ameloblastoma and that this factor has a prognostic value.
  • [MeSH-major] Ameloblastoma / surgery. Jaw Neoplasms / surgery. Neoplasm Recurrence, Local / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16245761.001).
  • [ISSN] 0251-172X
  • [Journal-full-title] Odonto-stomatologie tropicale = Tropical dental journal
  • [ISO-abbreviation] Odontostomatol Trop
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Senegal
  •  go-up   go-down


17. Matijević M, Leović D, Popić B, Zubcić V, Kopić V, Prlić A, Siber S, Dinjar K: The importance of thorough preoperative diagnostics of maxillary ameloblastoma: report of three cases. Coll Antropol; 2010 Dec;34(4):1445-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The importance of thorough preoperative diagnostics of maxillary ameloblastoma: report of three cases.
  • Ameloblastoma, especially maxillary, is a rare benign neoplasm of odontogenic origin.
  • Diagnosis of significant number of lesions is usually established postoperatively, because ameloblastoma, especially the unicystic form, mimics wide range of more frequent jaw lesions.
  • From January 1993 to December 2005, three cases of the maxillary ameloblastoma were surgically treated at our Department.
  • [MeSH-major] Ameloblastoma / diagnosis. Maxillary Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21874736.001).
  • [ISSN] 0350-6134
  • [Journal-full-title] Collegium antropologicum
  • [ISO-abbreviation] Coll Antropol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Croatia
  •  go-up   go-down


18. Tsujigiwa H, Nagatsuka H, Han PP, Gunduz M, Siar CH, Oida S, Nagai N: Analysis of amelogenin gene (AMGX, AMGY) expression in ameloblastoma. Oral Oncol; 2005 Sep;41(8):843-50
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Analysis of amelogenin gene (AMGX, AMGY) expression in ameloblastoma.
  • Although the amelogenin gene is expressed in ameloblastoma, the precise expression pattern of X and Y amelogenin genes (AMGX, AMGY) in this tumor has not yet been identified.
  • We postulate that epigenetic change of sex chromosomes may have some correlations with tumorigenesis of ameloblastoma.
  • [MeSH-major] Ameloblastoma / genetics. Dental Enamel Proteins / genetics. Jaw Neoplasms / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15979380.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Amelogenin; 0 / Dental Enamel Proteins
  •  go-up   go-down


19. Zhong M, Liu JD, Wang J, Liu J, Li L, Hou L, Zhang B: [Expression and significance of hTERT, c-fos and c-jun in ameloblastoma]. Shanghai Kou Qiang Yi Xue; 2006 Oct;15(5):461-5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expression and significance of hTERT, c-fos and c-jun in ameloblastoma].
  • PURPOSE: To investigate the expression of c-fos, c-jun and hTERT mRNA in human ameloblastoma (AB) and to determine their clinicobiological significance.
  • [MeSH-major] Ameloblastoma / metabolism. Jaw Neoplasms / metabolism. RNA, Messenger / metabolism

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17348214.001).
  • [ISSN] 1006-7248
  • [Journal-full-title] Shanghai kou qiang yi xue = Shanghai journal of stomatology
  • [ISO-abbreviation] Shanghai Kou Qiang Yi Xue
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / RNA, Messenger
  •  go-up   go-down


20. Jiang LJ, Shao CK, He D, Li WG, Wu XZ, Cai DZ: [Correlations of extrocellular matrix metalloproteinase inducer and microvessel density to invasiveness of ameloblastoma]. Ai Zheng; 2008 Dec;27(12):1263-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Correlations of extrocellular matrix metalloproteinase inducer and microvessel density to invasiveness of ameloblastoma].
  • METHODS: EMMPRIN expression and MVD in 41 specimens of ameloblastoma and 40 specimens of odontogenic cyst were examined by SP immuno-histochemistry.
  • CONCLUSION: EMMPRIN may play an important role during the progression of ameloblastoma via controlling angiogenesis and degradation of extracellular MMPs.
  • [MeSH-major] Ameloblastoma / metabolism. Antigens, CD147 / metabolism. Jaw Neoplasms / metabolism. Microvessels / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19079990.001).
  • [Journal-full-title] Ai zheng = Aizheng = Chinese journal of cancer
  • [ISO-abbreviation] Ai Zheng
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 136894-56-9 / Antigens, CD147
  •  go-up   go-down


26. Zhong M, Yan Y, Wang J, Liu J, Li L, Gong YB: [DNA methylation of human telomerase reverse transcriptase promoter region in human ameloblastoma]. Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 May;42(5):304-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [DNA methylation of human telomerase reverse transcriptase promoter region in human ameloblastoma].
  • OBJECTIVE: To study the DNA methylation of human telomerase reverse transcriptase (hTERT) promoter in ameloblastoma (AB) and investigate its clinical biological significance.
  • [MeSH-major] Ameloblastoma / genetics. DNA Methylation. Telomerase / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Gene Expression Regulation, Neoplastic. Humans. Jaw Neoplasms / genetics. Male. Middle Aged. Promoter Regions, Genetic / genetics. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17686286.001).
  • [ISSN] 1002-0098
  • [Journal-full-title] Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
  • [ISO-abbreviation] Zhonghua Kou Qiang Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] EC 2.7.7.49 / TERT protein, human; EC 2.7.7.49 / Telomerase
  •  go-up   go-down


27. Mikou A, Al Bouzidi A, Kabbaj R, Chahdi H, Kamous W, Zoubeir Y, Rharrassi I, Rimani M, Labraimi A, El Khatib M, Rzin A, Nassih M: [Desmoplastic ameloblastoma in a 7 year old child]. Rev Laryngol Otol Rhinol (Bord); 2008;129(4-5):341-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Desmoplastic ameloblastoma in a 7 year old child].
  • Desmoplastic ameloblastoma is a benign, locally aggressive neoplasm of proliferating odontogenic epithelial origin.
  • A curetting of the lesion was carried out and the anatomopathologic examination retained the diagnosis of desmoplastic ameloblastoma.
  • In addition, the desmoplastic ameloblastoma is relatively rare, is characterized by an anatomical distribution, a radiological appearance and a morphological aspect differents from the traditional ameloblastoma.
  • [MeSH-major] Ameloblastoma. Jaw Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19408524.001).
  • [ISSN] 0035-1334
  • [Journal-full-title] Revue de laryngologie - otologie - rhinologie
  • [ISO-abbreviation] Rev Laryngol Otol Rhinol (Bord)
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


28. Arotiba GT, Arotiba JT, Taiwo AO: Biologic, anatomic and clinical considerations in the management of the classic intraosseous ameloblastoma of the jaws. Nig Q J Hosp Med; 2010 Apr-Jun;20(2):55-63

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biologic, anatomic and clinical considerations in the management of the classic intraosseous ameloblastoma of the jaws.
  • This paper reviews the types of surgical and nonsurgical treatment modalities that have been used to treat the classic intraosseous ameloblastoma of the jaws.
  • [MeSH-major] Ameloblastoma / surgery. Jaw Cysts / surgery. Jaw Neoplasms / surgery
  • [MeSH-minor] Hospitals, Teaching. Humans. Jaw / pathology. Jaw / physiology. Jaw / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21243853.001).
  • [ISSN] 0189-2657
  • [Journal-full-title] Nigerian quarterly journal of hospital medicine
  • [ISO-abbreviation] Nig Q J Hosp Med
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Nigeria
  •  go-up   go-down


29. Konouchi H, Asaumi J, Yanagi Y, Hisatomi M, Kawai N, Matsuzaki H, Kishi K: Usefulness of contrast enhanced-MRI in the diagnosis of unicystic ameloblastoma. Oral Oncol; 2006 May;42(5):481-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Usefulness of contrast enhanced-MRI in the diagnosis of unicystic ameloblastoma.
  • The radiographic features of unicystic ameloblastoma (UA) are typically unilocular and round area of radiolucency.
  • [MeSH-major] Ameloblastoma / diagnosis. Jaw Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16488178.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


30. Pitak-Arnnop P, Chaine A, Dhanuthai K, Bertrand JC, Bertolus C: Unicystic ameloblastoma of the maxillary sinus: Pitfalls of diagnosis and management. Hippokratia; 2010 Jul;14(3):217-20

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unicystic ameloblastoma of the maxillary sinus: Pitfalls of diagnosis and management.
  • BACKGROUND: Ameloblastoma is a common odontogenic tumor of the jaws that comprises 3 variants: conventional (solid), unicystic and peripheral ameloblastomas.
  • Unicystic ameloblastoma (UA) in the maxillary sinus is very rare.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20981175.001).
  • [ISSN] 1790-8019
  • [Journal-full-title] Hippokratia
  • [ISO-abbreviation] Hippokratia
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Other-IDs] NLM/ PMC2943364
  • [Keywords] NOTNLM ; jaw tumor / maxillary sinus / orofacial infection / unicystic ameloblastoma
  •  go-up   go-down


31. Gümgüm S, Hoşgören B: Clinical and radiologic behaviour of ameloblastoma in 4 cases. J Can Dent Assoc; 2005 Jul-Aug;71(7):481-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical and radiologic behaviour of ameloblastoma in 4 cases.
  • Ameloblastoma is a benign but locally aggressive epithelial odontogenic neoplasm.
  • It represents 1% of all tumours of the jaw bone.
  • In 80% of cases, it is localized in the mandibular molar and ascending ramus area, mostly associated with an unerupted tooth.
  • Ameloblastoma may be discovered during a routine radiographic examination or as a clinically observed developing mass.
  • We describe the clinical and radiologic behaviour of ameloblastoma and discuss treatment protocols and the possibility of conservative management of this tumour.
  • [MeSH-major] Ameloblastoma / pathology. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16026635.001).
  • [ISSN] 1488-2159
  • [Journal-full-title] Journal (Canadian Dental Association)
  • [ISO-abbreviation] J Can Dent Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Canada
  •  go-up   go-down


32. Zhong M, Liu J, Gong YB, Liu JD, Wang J, Zhang B: [Expression of p21WAF1, p27KIP1 and cyclin E in ameloblastoma]. Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jul;40(4):306-9
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expression of p21WAF1, p27KIP1 and cyclin E in ameloblastoma].
  • OBJECTIVE: To investigate the expression of cyclin E mRNA, p21(WAF1) mRNA and p27(KIP1) protein in human ameloblastoma (AB), and to explore the clinical and biological characteristics of AB.
  • [MeSH-major] Ameloblastoma / metabolism. Cyclin E / metabolism. Cyclin-Dependent Kinase Inhibitor p21 / metabolism. Intracellular Signaling Peptides and Proteins / metabolism. Jaw Neoplasms / metabolism. Oncogene Proteins / metabolism

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16191374.001).
  • [ISSN] 1002-0098
  • [Journal-full-title] Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
  • [ISO-abbreviation] Zhonghua Kou Qiang Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / CCNE1 protein, human; 0 / CDKN1A protein, human; 0 / CDKN1B protein, human; 0 / Cyclin E; 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / Intracellular Signaling Peptides and Proteins; 0 / Oncogene Proteins; 0 / RNA, Messenger; 147604-94-2 / Cyclin-Dependent Kinase Inhibitor p27
  •  go-up   go-down


33. Eckardt AM, Kokemüller H, Flemming P, Schultze A: Recurrent ameloblastoma following osseous reconstruction--a review of twenty years. J Craniomaxillofac Surg; 2009 Jan;37(1):36-41
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent ameloblastoma following osseous reconstruction--a review of twenty years.
  • BACKGROUND: The adequate therapy of ameloblastoma may require a compromise between the least destructive treatment possible of a benign tumour and a sufficiently radical method to prevent recurrences.
  • [MeSH-major] Ameloblastoma / pathology. Jaw Neoplasms / pathology. Neoplasm Recurrence, Local / pathology. Reconstructive Surgical Procedures
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Bone Transplantation. Child. Disease-Free Survival. Female. Follow-Up Studies. Humans. Male. Mandibular Neoplasms / pathology. Mandibular Neoplasms / surgery. Maxillary Neoplasms / pathology. Maxillary Neoplasms / surgery. Middle Aged. Retrospective Studies. Surgical Flaps. Young Adult

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19022680.001).
  • [ISSN] 1010-5182
  • [Journal-full-title] Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
  • [ISO-abbreviation] J Craniomaxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


34. Dalati T, Zhou H: Gorlin syndrome with ameloblastoma: a case report and review of literature. Cancer Invest; 2008 Dec;26(10):975-6
Genetic Alliance. consumer health - Nevoid basal cell carcinoma syndrome.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gorlin syndrome with ameloblastoma: a case report and review of literature.
  • The lesion was excised, and pathological examination established the diagnosis of ameloblastoma.
  • A review of literature about Gorlin syndrome with ameloblastoma is presented.
  • [MeSH-major] Ameloblastoma / complications. Basal Cell Nevus Syndrome / complications. Jaw Neoplasms / complications. Maxillary Neoplasms / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19093254.001).
  • [ISSN] 1532-4192
  • [Journal-full-title] Cancer investigation
  • [ISO-abbreviation] Cancer Invest.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


35. DeVilliers P, Liu H, Suggs C, Simmons D, Daly B, Zhang S, Raubenheimer E, Larsson A, Wright T: Calretinin expression in the differential diagnosis of human ameloblastoma and keratocystic odontogenic tumor. Am J Surg Pathol; 2008 Feb;32(2):256-60
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Calretinin expression in the differential diagnosis of human ameloblastoma and keratocystic odontogenic tumor.
  • Ameloblastoma is a benign, locally aggressive epithelial odontogenic tumor that has the potential to become malignant and produce metastasis to distant sites such as lungs and kidneys.
  • The expression of calretinin [calbindin2 (CALB2)] was investigated on both ameloblastoma and KCOT.
  • Nineteen cases of ameloblastoma and 17 cases of KCOT were stained with calretinin antiserum 18-0211 (Zymed, San Francisco, CA).
  • All cases (100%) of ameloblastoma showed positive calretinin staining, restricted to the neoplastic epithelial component and none (0%) of the 17 KCOTs showed positive calretinin staining.
  • Taken together, the results of this study strongly support calretinin as a useful immunohistochemical marker for ameloblastoma and malignant ameloblastoma and it can also be used in the differential diagnosis of KCOT.
  • [MeSH-major] Ameloblastoma / diagnosis. Biomarkers, Tumor / metabolism. Jaw Neoplasms / diagnosis. Odontogenic Cysts / diagnosis. Odontogenic Tumors / diagnosis. S100 Calcium Binding Protein G / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18223328.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Grant] United States / NIDCR NIH HHS / DE / DE016079
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CALB2 protein, human; 0 / Calbindin 2; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / S100 Calcium Binding Protein G
  •  go-up   go-down


36. Pogrel MA, Montes DM: Is there a role for enucleation in the management of ameloblastoma? Int J Oral Maxillofac Surg; 2009 Aug;38(8):807-12
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Is there a role for enucleation in the management of ameloblastoma?
  • This study aimed to determine the appropriate long-term management for ameloblastoma and the role of enucleation in the management of the subtypes of ameloblastoma (solid ameloblastomas, cystic ameloblastomas and peripheral ameloblastomas).
  • For the unicystic ameloblastoma recurrence rates are high for simple enucleation.
  • The intraluminal subtype of unicystic ameloblastoma may do well with enucleation, but the intramural subtype may not, and since these cannot be identified preoperatively more aggressive treatment is recommended, including peripheral ostectomy or enucleation with subsequent treatment of the surrounding bone with liquid nitrogen, Carnoy's solution, or similar physicochemical modality.
  • The peripheral ameloblastoma has a different origin and responds to local excision.
  • [MeSH-major] Ameloblastoma / surgery. Jaw Neoplasms / surgery
  • [MeSH-minor] Acetic Acid / therapeutic use. Chloroform / therapeutic use. Combined Modality Therapy. Cryosurgery. Ethanol / therapeutic use. Evidence-Based Dentistry. Humans. Mandible / surgery. Mandibular Neoplasms / surgery. Maxilla / surgery. Maxillary Neoplasms / surgery. Neoplasm Recurrence, Local / prevention & control. Osteotomy / methods. Randomized Controlled Trials as Topic

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. ETHANOL .
  • Hazardous Substances Data Bank. ACETIC ACID .
  • Hazardous Substances Data Bank. CHLOROFORM .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19297131.001).
  • [ISSN] 1399-0020
  • [Journal-full-title] International journal of oral and maxillofacial surgery
  • [ISO-abbreviation] Int J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Carnoy's solution; 3K9958V90M / Ethanol; 7V31YC746X / Chloroform; Q40Q9N063P / Acetic Acid
  • [Number-of-references] 60
  •  go-up   go-down


37. Hertog D, van der Waal I: Ameloblastoma of the jaws: a critical reappraisal based on a 40-years single institution experience. Oral Oncol; 2010 Jan;46(1):61-4
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ameloblastoma of the jaws: a critical reappraisal based on a 40-years single institution experience.
  • The 40-years of experience in a single institution with the treatment of previously untreated ameloblastoma have been reported, followed by a management protocol.
  • In 11 patients, a preoperative diagnosis of ameloblastoma was available.
  • In the remaining 14 patients the diagnosis of ameloblastoma was a postoperative one.
  • In one of the patients with a recurrence a cervical lymph node metastasis was detected at the same time, resulting in a diagnosis of metastasizing ameloblastoma.
  • [MeSH-major] Ameloblastoma / pathology. Jaw / pathology. Jaw Neoplasms / pathology. Neoplasm Recurrence, Local / pathology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20004134.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


38. Sandra F, Hendarmin L, Nakao Y, Nakamura N, Nakamura S: Inhibition of Akt and MAPK pathways elevated potential of TNFalpha in inducing apoptosis in ameloblastoma. Oral Oncol; 2006 Jan;42(1):39-45
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inhibition of Akt and MAPK pathways elevated potential of TNFalpha in inducing apoptosis in ameloblastoma.
  • In the present study, from the flow cytometry results, we found that the prolonged-treatment of TNFalpha until 24 h, resulted apoptosis in AM-1 cells (ameloblastoma cell line).
  • These results suggested that TNFalpha induced both cell survival and apoptosis pathways in ameloblastoma and potential of TNFalpha in inducing apoptosis can be improved by inhibiting TNFalpha-induced Akt and p44/42 mitogen-activated protein kinase (MAPK) cell survival pathways.
  • [MeSH-major] Ameloblastoma / physiopathology. Apoptosis / physiology. Jaw Neoplasms / physiopathology. Mitogen-Activated Protein Kinases / metabolism. Proto-Oncogene Proteins c-akt / metabolism. Tumor Necrosis Factor-alpha / pharmacology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16140562.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Enzyme Inhibitors; 0 / Fluorescent Dyes; 0 / Neoplasm Proteins; 0 / Tumor Necrosis Factor-alpha; EC 2.7.11.1 / AKT1 protein, human; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt; EC 2.7.11.24 / Mitogen-Activated Protein Kinases; EC 3.4.22.- / Caspases
  •  go-up   go-down


39. Sathi GA, Inoue M, Harada H, Rodriguez AP, Tamamura R, Tsujigiwa H, Borkosky SS, Gunduz M, Nagatsuka H: Secreted frizzled related protein (sFRP)-2 inhibits bone formation and promotes cell proliferation in ameloblastoma. Oral Oncol; 2009 Oct;45(10):856-60
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Secreted frizzled related protein (sFRP)-2 inhibits bone formation and promotes cell proliferation in ameloblastoma.
  • Secreted frizzled related protein (sFRP)-2, a Wnt antagonist, was strongly expressed by both stromal and tumor cells of ameloblastoma.
  • A pre-osteoblastic cell line, KUSA/A1 cells, cultured in conditioned medium of an ameloblastoma-derived cell line (AM-1CM) was used in the study.
  • KUSA/A1 cells cultured in AM-1CM showed high cell proliferation, low ALP activity without mineralized matrix deposition. sFRP-2 was strongly expressed in ameloblastoma tissue and AM-1 cells.
  • In this study, it was confirmed that ameloblastoma cells have a major role in decreased bone formation by secreting sFRP-2 in cell culture model.
  • Though, sFRP-2 has great effect on tumor progression, inhibition of sFRP-2's anti-bone formation activity and cell proliferative activity may reduce the invasive property of ameloblastoma and possibility of recurrence rate.
  • [MeSH-major] Ameloblastoma / metabolism. Cell Proliferation. Jaw Neoplasms / metabolism. Membrane Proteins / physiology. Neoplasm Proteins / physiology. Osteogenesis / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19362047.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Membrane Proteins; 0 / Neoplasm Proteins; 0 / SFRP2 protein, human; 0 / Wnt Proteins; EC 3.1.3.1 / Alkaline Phosphatase
  •  go-up   go-down


40. Tanahashi J, Daa T, Yada N, Kashima K, Kondoh Y, Yokoyama S: Mutational analysis of Wnt signaling molecules in ameloblastoma with aberrant nuclear expression of beta-catenin. J Oral Pathol Med; 2008 Oct;37(9):565-70
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mutational analysis of Wnt signaling molecules in ameloblastoma with aberrant nuclear expression of beta-catenin.
  • BACKGROUND: To clarify the genetic background of ameloblastoma, expression of beta-catenin, and mutational status of genes involved in Wnt signaling pathway were investigated.
  • METHODS: We analyzed beta-catenin and cyclin D1 in 18 cases of ameloblastoma by immunohistochemical staining, and searched for mutations in CTNNB1 (gene for beta-catenin), APC, AXIN1, and AXIN2 by polymerase chain reaction (PCR) and direct sequencing method.
  • [MeSH-major] Ameloblastoma / metabolism. Cell Nucleus / metabolism. Cyclin D1 / metabolism. Jaw Neoplasms / metabolism. Wnt Proteins / genetics. beta Catenin / metabolism

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18284543.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Wnt Proteins; 0 / beta Catenin; 136601-57-5 / Cyclin D1
  •  go-up   go-down


41. Eslami B, Lorente C, Kieff D, Caruso PA, Faquin WC: Ameloblastoma associated with the nevoid basal cell carcinoma (Gorlin) syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jun;105(6):e10-3
Genetic Alliance. consumer health - Nevoid basal cell carcinoma syndrome.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ameloblastoma associated with the nevoid basal cell carcinoma (Gorlin) syndrome.
  • Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder characterized by a wide range of clinical signs and symptoms.
  • The major criteria for the diagnosis are multiple cutaneous basal cell carcinomas, multiple odontogenic keratocysts of the jaw, palmar and plantar pits, and skeletal abnormalities.
  • Here, we report an unusual case of NBCCS in a 68-year-old woman with late onset of clinical signs and symptoms and with an associated ameloblastoma.
  • [MeSH-major] Ameloblastoma / etiology. Basal Cell Nevus Syndrome / complications. Jaw Neoplasms / complications. Maxillary Neoplasms / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18417377.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptors, Cell Surface; 0 / patched receptors
  •  go-up   go-down


42. Souza Andrade ES, da Costa Miguel MC, Pinto LP, de Souza LB: Ameloblastoma and adenomatoid odontogenic tumor: the role of alpha2beta1, alpha3beta1, and alpha5beta1 integrins in local invasiveness and architectural characteristics. Ann Diagn Pathol; 2007 Jun;11(3):199-205

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ameloblastoma and adenomatoid odontogenic tumor: the role of alpha2beta1, alpha3beta1, and alpha5beta1 integrins in local invasiveness and architectural characteristics.
  • Ameloblastoma is an odontogenic neoplasm characterized by local invasiveness and a tendency toward recurrence, whereas adenomatoid odontogenic tumor (AOT) is an indolent neoplasm.
  • A difference in the pattern of integrin expression was observed between the various histologic types of ameloblastoma.
  • [MeSH-major] Ameloblastoma / pathology. Integrin alpha2beta1 / physiology. Integrin alpha3beta1 / physiology. Integrin alpha5beta1 / physiology. Jaw Neoplasms / pathology. Odontogenic Tumors / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17498594.001).
  • [ISSN] 1092-9134
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Integrin alpha2beta1; 0 / Integrin alpha3beta1; 0 / Integrin alpha5beta1
  •  go-up   go-down


43. Arotiba GT, Ladeinde AL, Arotiba JT, Ajike SO, Ugboko VI, Ajayi OF: Ameloblastoma in Nigerian children and adolescents: a review of 79 cases. J Oral Maxillofac Surg; 2005 Jun;63(6):747-51

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ameloblastoma in Nigerian children and adolescents: a review of 79 cases.
  • PURPOSE: To descriptively review the clinicopathologic presentation and management of ameloblastoma in Nigerian children and adolescents and compare this with previous reports in the literature.
  • RESULTS: Out of a total of 360 patients with a diagnosis of ameloblastoma, 79 were under 20 years of age at presentation (21.9%).
  • The most common morphologic type was solid multicystic ameloblastoma (82.3%).
  • However, exclusively anterior tumors constituted only 15.2% of the cases, while tumors involving anterior and posterior jaw regions constituted 41.1%.
  • CONCLUSION: Ameloblastoma in Nigerian children and adolescents exhibit some peculiar clinical features: these include the predominance of males, and of the solid multicystic morphologic type.
  • [MeSH-major] Ameloblastoma / pathology. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15944968.001).
  • [ISSN] 0278-2391
  • [Journal-full-title] Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • [ISO-abbreviation] J. Oral Maxillofac. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


44. Desai H, Sood R, Shah R, Cawda J, Pandya H: Desmoplastic ameloblastoma: report of a unique case and review of literature. Indian J Dent Res; 2006 Jan-Mar;17(1):45-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoplastic ameloblastoma: report of a unique case and review of literature.
  • Desmoplastic Ameloblastoma is a rare variant of ameloblastoma.
  • 90 cases of desmoplastic ameloblastoma have been reported so far in literature.
  • We are presenting a rare case of desmoplastic ameloblastoma in the ramus region of mandible with regards to its clinical and radiographical viewpoints.
  • Only one other case of desmoplastic ameloblastoma has been reported in the ramus region of mandible of the 90 cases that we have reviewed.
  • The anterior region of either jaw was most commonly found to be affected.
  • [MeSH-major] Ameloblastoma / diagnosis. Mandibular Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16900895.001).
  • [ISSN] 0970-9290
  • [Journal-full-title] Indian journal of dental research : official publication of Indian Society for Dental Research
  • [ISO-abbreviation] Indian J Dent Res
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] India
  • [Chemical-registry-number] 9007-34-5 / Collagen
  • [Number-of-references] 21
  •  go-up   go-down


45. Ide F, Mishima K, Yamada H, Horie N, Saito I, Shimoyama T, Kusama K: Unsuspected small ameloblastoma in the alveolar bone: a collaborative study of 14 cases with discussion of their cellular sources. J Oral Pathol Med; 2008 Apr;37(4):221-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unsuspected small ameloblastoma in the alveolar bone: a collaborative study of 14 cases with discussion of their cellular sources.
  • BACKGROUND: Intraosseous ameloblastoma (IA) is the quintessence of epithelial odontogenic tumor and histologically and behaviorally defined as an undoubted neoplastic process.
  • [MeSH-major] Alveolar Process / pathology. Ameloblastoma / pathology. Jaw Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18221325.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Denmark
  • [Number-of-references] 48
  •  go-up   go-down


46. Zhang B, Zhang J, Huang HZ, Chen WL, Tao Q, Zeng DL, Zhang LT, Xu JH: Inhibition of ameloblastoma invasion in vitro and in vivo by inhibitor of metalloproteinase-2 activity. J Oral Pathol Med; 2009 Oct;38(9):731-6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inhibition of ameloblastoma invasion in vitro and in vivo by inhibitor of metalloproteinase-2 activity.
  • BACKGROUND: Ameloblastoma is an odontogenic benign tumor characterized by local invasiveness and most of its local recurrences clinically result from local invasion.
  • This study used matrix metalloproteinase-2 (MMP-2) inhibitor I (MMP-2I) to investigate the role played by MMP-2 activity in the local invasiveness of ameloblastoma.
  • METHODS: The cells and xenografts of ameloblastoma were treated with MMP-2I and treatment group were compared with the control group.
  • In vivo, bilateral subrenal capsule xenograft transplantation of ameloblastoma was performed in 10 nude mice and the invasion of ameloblastoma into the renal parenchyma was observed.
  • CONCLUSIONS: Inhibitor of MMP-2 activity suppressed the local invasive capability of ameloblastoma by decreasing MMP-2 activity.
  • MMP-2 activity is in relation with invasive capacity of ameloblastoma.
  • [MeSH-major] Ameloblastoma / enzymology. Jaw Neoplasms / enzymology. Matrix Metalloproteinase Inhibitors. Tissue Inhibitor of Metalloproteinase-2 / pharmacology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19473446.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Matrix Metalloproteinase Inhibitors; 127497-59-0 / Tissue Inhibitor of Metalloproteinase-2; EC 3.4.24.24 / Matrix Metalloproteinase 2
  •  go-up   go-down


47. Jivan V, Altini M, Meer S, Mahomed F: Adenomatoid odontogenic tumor (AOT) originating in a unicystic ameloblastoma: a case report. Head Neck Pathol; 2007 Dec;1(2):146-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenomatoid odontogenic tumor (AOT) originating in a unicystic ameloblastoma: a case report.
  • This paper presents a case of an extra-follicular AOT, which we believe originated from the epithelial lining of a unicystic ameloblastoma, and reviews the literature.
  • [MeSH-major] Adenomatoid Tumor / pathology. Ameloblastoma / pathology. Jaw Neoplasms / pathology. Odontogenic Tumors / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oral Dis. 2003 Jan;9(1):1-6 [12617250.001]
  • [Cites] Histopathology. 2001 Apr;38(4):312-7 [11318896.001]
  • [Cites] J Oral Pathol Med. 1991 Apr;20(4):149-58 [2061853.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1991 Jul;72(1):91-4 [1891249.001]
  • [Cites] J Oral Maxillofac Surg. 1992 Feb;50(2):190-3 [1732497.001]
  • [Cites] J Oral Maxillofac Surg. 1992 Mar;50(3):282-5 [1542070.001]
  • [Cites] J Oral Pathol Med. 1992 Sep;21(8):348-52 [1403843.001]
  • [Cites] J Oral Maxillofac Surg. 1995 Jun;53(6):714-7 [7776060.001]
  • [Cites] J Oral Pathol Med. 1995 May;24(5):227-32 [7616462.001]
  • [Cites] J Oral Maxillofac Surg. 1996 May;54(5):634-7 [8632252.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Sep;86(3):313-7 [9768421.001]
  • [Cites] J Clin Pediatr Dent. 1998 Fall;23(1):55-8 [10023235.001]
  • [Cites] Oral Oncol. 2005 Feb;41(2):214-5 [15695124.001]
  • [Cites] Oral Oncol. 2005 Sep;41(8):835-42 [15979930.001]
  • [Cites] J Oral Pathol Med. 2001 Apr;30(4):237-44 [11302244.001]
  • [Cites] Histopathology. 2000 Jul;37(1):27-32 [10931215.001]
  • [Cites] Oral Dis. 2006 Mar;12(2):200-3 [16476044.001]
  • [Cites] J Oral Pathol Med. 2001 Apr;30(4):251-4 [11302246.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1972 Sep;34(3):450-6 [4505759.001]
  • (PMID = 20614266.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Calbindin 2; 0 / S100 Calcium Binding Protein G
  • [Other-IDs] NLM/ PMC2807512
  • [Keywords] NOTNLM ; Adenomatoid odontogenic tumor / Extra-follicular / Unicystic ameloblastoma
  •  go-up   go-down


48. Sathi GS, Nagatsuka H, Tamamura R, Fujii M, Gunduz M, Inoue M, Rivera RS, Nagai N: Stromal cells promote bone invasion by suppressing bone formation in ameloblastoma. Histopathology; 2008 Oct;53(4):458-67
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Stromal cells promote bone invasion by suppressing bone formation in ameloblastoma.
  • AIMS: To study the stromal variation and role of stromal-tumour cell interaction in impaired bone formation as well as enhanced bone resorption in ameloblastoma.
  • [MeSH-major] Ameloblastoma / pathology. Bone and Bones / metabolism. Jaw Neoplasms / pathology. Osteogenesis / physiology. Stromal Cells / metabolism

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18983611.001).
  • [ISSN] 1365-2559
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, Differentiation, Myelomonocytic; 0 / CD68 antigen, human; 0 / Interleukin-6; 0 / Membrane Proteins; 0 / RANK Ligand; 0 / SFRP2 protein, human
  •  go-up   go-down


49. Oliveira-Neto HH, Spíndula-Filho JV, Dallara MC, Silva CM, Mendonça EF, Batista AC: Unicystic ameloblastoma in a child: a differential diagnosis from the dentigerous cyst and the inflammatory follicular cyst. J Dent Child (Chic); 2007 Sep-Dec;74(3):245-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unicystic ameloblastoma in a child: a differential diagnosis from the dentigerous cyst and the inflammatory follicular cyst.
  • Unicystic ameloblastoma (UA) is a benign epithelial odontogenic tumor of the jaws with an aggressive potential that commonly occurs in children.
  • The purposes of this report were to describe a case of UA involving the crown of the unerupted right mandibular second premolar in an 11-year-old girl under orthodontic treatment, and discuss its diagnosis and radiographic and microscopic findings, emphasizing its distinction from the dentigerous cyst and the inflammatory follicular cyst.
  • [MeSH-major] Ameloblastoma / pathology. Jaw Cysts / pathology. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18482524.001).
  • [ISSN] 1935-5068
  • [Journal-full-title] Journal of dentistry for children (Chicago, Ill.)
  • [ISO-abbreviation] J Dent Child (Chic)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


50. Chukwuneke FN, Ajuzieogu O, Chukwuka A, Okwuowulu T, Nnodi P, Oji C: Surgical challenges in the treatment of advanced cases of ameloblastoma in the developing world: The authors' experience. Int J Oral Maxillofac Surg; 2010 Feb;39(2):150-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical challenges in the treatment of advanced cases of ameloblastoma in the developing world: The authors' experience.
  • Total mandibulectomy was carried out in 32 patients with extensive oro-facial lesions histologically diagnosed as ameloblastoma in four specialist centres in south-eastern Nigeria from January 2001 to December 2006.
  • Generally, the postoperative recovery was characterized by reduction in the quality of life of these patients because immediate jaw reconstruction was not feasible.
  • This article highlights the challenges in the surgical management of advanced cases of ameloblastoma in the developing world and proposes a middle ground for professional interactions and exchange programmes among oral and maxillofacial surgeons across the world to assist poorer countries in the management of these advanced cases of oro-facial tumours.
  • [MeSH-major] Ameloblastoma / surgery. Developing Countries. Mandibular Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 20047817.001).
  • [ISSN] 1399-0020
  • [Journal-full-title] International journal of oral and maxillofacial surgery
  • [ISO-abbreviation] Int J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] Denmark
  •  go-up   go-down


51. Borkosky SS, Gunduz M, Beder L, Tsujigiwa H, Tamamura R, Gunduz E, Katase N, Rodriguez AP, Sasaki A, Nagai N, Nagatsuka H: Allelic loss of the ING gene family loci is a frequent event in ameloblastoma. Oncol Res; 2010;18(10):509-18
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Allelic loss of the ING gene family loci is a frequent event in ameloblastoma.
  • Ameloblastoma is the most frequently encountered odontogenic tumor, characterized by a locally invasive behavior, frequent recurrences, and, although rare, metastatic capacity.
  • TP53 genetic alterations were reported to infrequently occur in ameloblastoma.
  • LOH of ING family genes appears as a common genetic alteration in solid ameloblastoma.
  • The current study provides interesting novel information regarding the potential prognostic significance of the allelic loss of the ING gene family loci in ameloblastoma tumorigenesis.
  • [MeSH-major] Ameloblastoma / genetics. Cell Cycle Proteins / genetics. Homeodomain Proteins / genetics. Intracellular Signaling Peptides and Proteins / genetics. Jaw Neoplasms / genetics. Loss of Heterozygosity. Nuclear Proteins / genetics. Trans-Activators / genetics. Tumor Suppressor Proteins / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20681410.001).
  • [ISSN] 0965-0407
  • [Journal-full-title] Oncology research
  • [ISO-abbreviation] Oncol. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / Homeodomain Proteins; 0 / ING1 protein, human; 0 / ING3 protein, human; 0 / ING4 protein, human; 0 / Intracellular Signaling Peptides and Proteins; 0 / Nuclear Proteins; 0 / Trans-Activators; 0 / Tumor Suppressor Proteins
  •  go-up   go-down


52. Lau SL, Samman N: Recurrence related to treatment modalities of unicystic ameloblastoma: a systematic review. Int J Oral Maxillofac Surg; 2006 Aug;35(8):681-90

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrence related to treatment modalities of unicystic ameloblastoma: a systematic review.
  • This systematic review aims to identify all studies pertinent to the clinical question, 'which treatment for unicystic ameloblastoma results in the lowest recurrence rate?
  • It was concluded that there is only weak evidence showing that jaw resection resulted in the lowest recurrence rate, followed by enucleation with application of Carnoy's solution.
  • [MeSH-major] Ameloblastoma / surgery. Cysts / surgery. Jaw Neoplasms / surgery. Neoplasm Recurrence, Local. Oral Surgical Procedures / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16782308.001).
  • [ISSN] 0901-5027
  • [Journal-full-title] International journal of oral and maxillofacial surgery
  • [ISO-abbreviation] Int J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Carnoy's solution; 3K9958V90M / Ethanol; 7V31YC746X / Chloroform; Q40Q9N063P / Acetic Acid
  • [Number-of-references] 90
  •  go-up   go-down


53. Wang A, Zhang B, Huang H, Zhang L, Zeng D, Tao Q, Wang J, Pan C: Suppression of local invasion of ameloblastoma by inhibition of matrix metalloproteinase-2 in vitro. BMC Cancer; 2008;8:182
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Suppression of local invasion of ameloblastoma by inhibition of matrix metalloproteinase-2 in vitro.
  • METHODS: Plasmids containing either MMP-2 siRNA or tissue inhibitor of metalloproteinase-2 (TIMP-2) cDNA were created and subsequently transfected into primary ameloblastoma cells.
  • RESULTS: Primary cultures of ameloblastoma cells expressed cytokeratin (CK) 14 and 16, and MMP-2, but only weakly expressed CK18 and vimentin.
  • Both MMP-2 siRNA and TIMP-2 overexpression inhibited MMP-2 activity and the in vitro invasiveness of ameloblastoma.
  • CONCLUSION: These results indicate that inhibition of MMP-2 activity suppresses the local invasiveness of ameloblastoma cells.
  • [MeSH-major] Ameloblastoma / enzymology. Jaw Neoplasms / enzymology. Matrix Metalloproteinase Inhibitors

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 1994 Sep 1;54(17):4726-8 [8062271.001]
  • [Cites] Methods. 2002 Feb;26(2):199-213 [12054897.001]
  • [Cites] Semin Cancer Biol. 1996 Jun;7(3):147-54 [8773300.001]
  • [Cites] J Dent Res. 2002 Aug;81(8):525-30 [12147741.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Aug 30;296(4):1000-4 [12200148.001]
  • [Cites] J Oral Pathol Med. 2003 Feb;32(2):114-20 [12542835.001]
  • [Cites] Antisense Nucleic Acid Drug Dev. 2003 Feb;13(1):1-7 [12691531.001]
  • [Cites] Quintessence Int. 2003 Apr;34(4):311-4 [12731620.001]
  • [Cites] J Pathol. 2003 Jul;200(4):448-64 [12845612.001]
  • [Cites] Clin Exp Metastasis. 2003;20(7):585-92 [14669789.001]
  • [Cites] Ann Otol Rhinol Laryngol. 2003 Dec;112(12):1034-9 [14703106.001]
  • [Cites] Biochem Biophys Res Commun. 2004 Jan 30;314(1):283-91 [14715277.001]
  • [Cites] Shanghai Kou Qiang Yi Xue. 2003 Dec;12(6):427-31 [14966582.001]
  • [Cites] Zhonghua Kou Qiang Yi Xue Za Zhi. 2004 Jan;39(1):45-8 [14989873.001]
  • [Cites] Histopathology. 2004 Jul;45(1):65-72 [15228445.001]
  • [Cites] Semin Cancer Biol. 1990 Apr;1(2):99-106 [2103492.001]
  • [Cites] Br J Cancer. 1996 Nov;74(9):1354-8 [8912529.001]
  • [Cites] Chem Biol. 1996 Nov;3(11):895-904 [8939708.001]
  • [Cites] Biol Chem. 1997 Mar-Apr;378(3-4):151-60 [9165065.001]
  • [Cites] Br J Cancer. 1997;76(6):805-11 [9310250.001]
  • [Cites] J Oral Pathol Med. 2006 Feb;35(2):65-74 [16430735.001]
  • [Cites] Hua Xi Kou Qiang Yi Xue Za Zhi. 2006 Feb;24(1):7-10 [16541644.001]
  • [Cites] Mol Cancer Ther. 2006 Sep;5(9):2289-99 [16985063.001]
  • [Cites] J Dent Res. 2006 Dec;85(12):1074-84 [17122157.001]
  • [Cites] J Gene Med. 2007 Mar;9(3):217-29 [17351970.001]
  • [Cites] Cancer Res. 2007 May 15;67(10):4956-64 [17510426.001]
  • [Cites] Oncogene. 2007 Dec 6;26(55):7675-83 [17599056.001]
  • [Cites] Crit Rev Oral Biol Med. 1993;4(2):197-250 [8435466.001]
  • [Cites] Virchows Arch. 1999 Dec;435(6):566-73 [10628798.001]
  • [Cites] Oral Dis. 2000 Nov;6(6):376-82 [11355270.001]
  • [Cites] Anal Biochem. 1994 May 1;218(2):325-9 [8074288.001]
  • (PMID = 18588710.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Matrix Metalloproteinase Inhibitors; 0 / RNA, Messenger; 0 / RNA, Small Interfering; 127497-59-0 / Tissue Inhibitor of Metalloproteinase-2; EC 3.4.24.24 / Matrix Metalloproteinase 2
  • [Other-IDs] NLM/ PMC2443806
  •  go-up   go-down


54. Krishnapillai R, Angadi PV: A clinical, radiographic, and histologic review of 73 cases of ameloblastoma in an Indian population. Quintessence Int; 2010 May;41(5):e90-100

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A clinical, radiographic, and histologic review of 73 cases of ameloblastoma in an Indian population.
  • The present study was undertaken to retrospectively compare the clinical, radiologic, and histopathologic features of 73 cases of ameloblastoma in Indians.
  • METHOD AND MATERIALS: Biopsy records of 73 histologically diagnosed cases of ameloblastoma over an 18-year period were retrieved and analyzed for age, sex, site distribution, clinical presentation, radiologic features, and histopathology.
  • RESULTS: Ameloblastoma accounted for 60.3% of all odontogenic tumors in this study, with a mean age of presentation of 30.2 years.
  • A slight male predilection and predominant occurrence in the mandibular molar-ramus area were noted.
  • Radiologically, ameloblastoma presented as either unilocular or multilocular radiolucency, with a significant age difference noted between unilocular and multilocular lesions.
  • The most common histologic type in contrast to other studies was unicystic ameloblastoma followed by follicular and acanthomatous ameloblastoma.
  • Recurrence was seen in 13.3% of patients, predominantly in males, in the molar-ramus area, and the common histologic type was follicular ameloblastoma followed by unicystic ameloblastoma.
  • CONCLUSION: The finding of unicystic ameloblastoma being the second most common recurrent variant of ameloblastoma, especially when associated with cyst wall invasion or intramural proliferation, may warrant a more aggressive treatment than traditional enucleation/curettage for this entity to prevent recurrence.
  • [MeSH-major] Ameloblastoma / pathology. Jaw Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20376369.001).
  • [ISSN] 1936-7163
  • [Journal-full-title] Quintessence international (Berlin, Germany : 1985)
  • [ISO-abbreviation] Quintessence Int
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


55. Hendarmin L, Sandra F, Nakao Y, Ohishi M, Nakamura N: TNFalpha played a role in induction of Akt and MAPK signals in ameloblastoma. Oral Oncol; 2005 Apr;41(4):375-82
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] TNFalpha played a role in induction of Akt and MAPK signals in ameloblastoma.
  • In the present study, we found that TNFalpha as well as its receptors, TNFR1 (TNF Receptor 1) and TNFR2, were clearly expressed in ameloblastoma tissues and AM-1 cells.
  • These results suggested that TNFalpha is expressed in ameloblastoma and it can induce Akt and p44/42 MAPK activation through PI3K, which later might induce cell survival and proliferation in ameloblastoma.
  • [MeSH-major] Ameloblastoma / metabolism. Jaw Neoplasms / metabolism. Mitogen-Activated Protein Kinases / metabolism. Protein-Serine-Threonine Kinases / metabolism. Proto-Oncogene Proteins / metabolism. Tumor Necrosis Factor-alpha / physiology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15792609.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Neoplasm Proteins; 0 / Proto-Oncogene Proteins; 0 / Receptors, Tumor Necrosis Factor, Type I; 0 / Receptors, Tumor Necrosis Factor, Type II; 0 / Tumor Necrosis Factor-alpha; EC 2.7.1.- / Phosphatidylinositol 3-Kinases; EC 2.7.11.1 / AKT1 protein, human; EC 2.7.11.1 / Protein-Serine-Threonine Kinases; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt; EC 2.7.11.24 / Mitogen-Activated Protein Kinases
  •  go-up   go-down


56. Tao Q, Lv B, Qiao B, Zheng CQ, Chen ZF: Immortalization of ameloblastoma cells via reactivation of telomerase function: Phenotypic and molecular characteristics. Oral Oncol; 2009 Dec;45(12):e239-44
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immortalization of ameloblastoma cells via reactivation of telomerase function: Phenotypic and molecular characteristics.
  • Ameloblastoma (AM) is recognized as a benign tumour but locally invasive with a high risk of recurrence.
  • [MeSH-major] Ameloblastoma / pathology. Jaw Neoplasms / pathology. Neoplasm Proteins / metabolism. Telomerase / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19833545.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Neoplasm Proteins; EC 2.7.7.49 / TERT protein, human; EC 2.7.7.49 / Telomerase
  •  go-up   go-down


57. González-García R, Sastre-Pérez J, Nam-Cha SH, Muñoz-Guerra MF, Rodríguez-Campo FJ, Naval-Gías L: Primary intraosseous carcinomas of the jaws arising within an odontogenic cyst, ameloblastoma, and de novo: report of new cases with reconstruction considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb;103(2):e29-33

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary intraosseous carcinomas of the jaws arising within an odontogenic cyst, ameloblastoma, and de novo: report of new cases with reconstruction considerations.
  • The authors report 3 new cases of PIOC arising within an odontogenic cyst, ameloblastoma, and de novo origin, respectively.
  • [MeSH-major] Jaw Neoplasms / etiology. Odontogenic Tumors / etiology. Oral Surgical Procedures / methods
  • [MeSH-minor] Adult. Aged. Ameloblastoma / complications. Humans. Male. Odontogenic Cysts / complications. Odontogenic Tumor, Squamous / pathology. Odontogenic Tumor, Squamous / surgery. Reconstructive Surgical Procedures / methods. Surgical Flaps

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17095253.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


58. Sarnat BG: Some selected dental and jaw aberrations. Ann Plast Surg; 2006 Oct;57(4):453-61

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Some selected dental and jaw aberrations.
  • Development of facial form is related to the synchronous coordination of 3-dimensional, multiple, differential dental and jaw growth sites and centers and associated structure activities.
  • This report deals with some selected unusual dental and jaw aberrations, some of which may have developed during the prenatal period and others during infancy and early childhood.
  • Dental histogenesis is correlated in several instances (anodontia, ameloblastoma, hemifacial, atrophy) with jaw implications.
  • [MeSH-major] Jaw Abnormalities. Tooth Abnormalities
  • [MeSH-minor] Animals. Facial Asymmetry / etiology. Facial Asymmetry / surgery. Humans. Jaw / embryology. Primates. Tooth / embryology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16998342.001).
  • [ISSN] 0148-7043
  • [Journal-full-title] Annals of plastic surgery
  • [ISO-abbreviation] Ann Plast Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 12
  •  go-up   go-down


59. Fiaschetti V, Fanucci E, Rascioni M, Ottria L, Barlattani A, Simonetti G: Jaw expansive lesions: population incidence and CT dentalscan role. Oral Implantol (Rome); 2010 Jul;3(3):2-10

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Jaw expansive lesions: population incidence and CT dentalscan role.
  • 656 patients (93.1 %) out of 704 examined for a suspicious lesion on the orthopantomography had a benign lesion: (127 follicular cysts (18.2 %), 181 radicular cysts (25.1%), 93 non odontogenic cysts (13.2%), 29 fibroma (4.2%), 198 odontomes (28.2%), 24 ameloblastoma (3.6%), 4 brown tumors (0.7%), 47 (6.9%) had malignant lesions: (12 carcinoma (1.7%), 29 metastasis (4.3%), 6 sarcoma (0.8%), 1 Dentascan CT resulted to be negative (1 false positive of digital OPT).
  • CONCLUSIONS: CT Dentascan characteristics suggest to consider these techniques as the gold standard for the evaluation of jaw expansive lesions and the support of surgical planning.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiol Clin North Am. 1993 Jan;31(1):163-80 [8419972.001]
  • [Cites] Semin Ultrasound CT MR. 1995 Dec;16(6):453-67 [8747412.001]
  • [Cites] Radiol Med. 1996 Jul-Aug;92(1-2):114-21 [8966249.001]
  • [Cites] AJR Am J Roentgenol. 1998 Apr;170(4):1085-91 [9530065.001]
  • [Cites] AJNR Am J Neuroradiol. 1999 Aug;20(7):1221-7 [10472975.001]
  • [Cites] Dentomaxillofac Radiol. 2000 Jan;29(1):35-40 [10654034.001]
  • [Cites] Radiol Med. 1999 Dec;98(6):447-53 [10755003.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Aug;90(2):249-53 [10936846.001]
  • [Cites] Radiology. 2001 May;219(2):334-45 [11323454.001]
  • [Cites] Clin Radiol. 2001 Sep;56(9):700-13 [11585392.001]
  • [Cites] Eur Radiol. 2002 Mar;12(3):634-7 [11870479.001]
  • [Cites] J Oral Sci. 2006 Mar;48(1):27-34 [16617198.001]
  • [Cites] Radiol Med. 2006 Feb;111(1):130-8 [16623313.001]
  • [Cites] Eur J Paediatr Dent. 2008 Jun;9(2):65-70 [18605887.001]
  • [Cites] Dent Clin North Am. 2008 Oct;52(4):707-30, v [18805225.001]
  • [Cites] Nig Q J Hosp Med. 2008 Jan-Mar;18(1):32-5 [19062469.001]
  • [Cites] Int J Med Robot. 2009 Dec;5(4):366-80 [19777550.001]
  • (PMID = 23285385.001).
  • [ISSN] 1974-5648
  • [Journal-full-title] ORAL & implantology
  • [ISO-abbreviation] Oral Implantol (Rome)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC3399186
  • [Keywords] NOTNLM ; dentalscan / expansive lesions
  •  go-up   go-down


60. Tsuneki M, Yamazaki M, Cheng J, Maruyama S, Kobayashi T, Saku T: Combined immunohistochemistry for the differential diagnosis of cystic jaw lesions: its practical use in surgical pathology. Histopathology; 2010 Dec;57(6):806-13
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined immunohistochemistry for the differential diagnosis of cystic jaw lesions: its practical use in surgical pathology.
  • AIMS: Histopathological distinction of cystic jaw lesions, including odontogenic tumours, is challenging because their lining epithelia, which are basically stratified squamous epithelia, resemble each other, especially when they become hyperplastic from inflammatory reaction.
  • CONCLUSIONS: Using a combination of six kinds of immunohistochemical pattern, it is now possible to discriminate reliably and objectively these five cystic jaw lesions in routine practice.
  • [MeSH-major] Ameloblastoma / pathology. Immunohistochemistry / methods. Jaw Diseases / pathology. Odontogenic Tumors / pathology. Periodontal Cyst / pathology. Radicular Cyst / pathology

  • MedlinePlus Health Information. consumer health - Jaw Injuries and Disorders.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 Blackwell Publishing Limited.
  • (PMID = 21166695.001).
  • [ISSN] 1365-2559
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


61. Reid-Nicholson M, Teague D, White B, Ramalingam P, Abdelsayed R: Fine needle aspiration findings in malignant ameloblastoma: a case report and differential diagnosis. Diagn Cytopathol; 2009 Aug;37(8):586-91

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fine needle aspiration findings in malignant ameloblastoma: a case report and differential diagnosis.
  • We present a case of malignant ameloblastoma presenting in the posterior mandible and cervical lymph nodes of an African American child.
  • This partly clinical as well as cytologic diagnosis was facilitated by the presence of typical ameloblastoma cytology in multiple cervical lymph nodes adjacent to the histologically confirmed intraosseous ameloblastoma.
  • Although cytology is helpful in diagnosing ameloblastoma, its features are by no means definitive as there are several cytologic mimics.
  • A high index of suspicion is therefore necessary to confirm or exclude ameloblastoma when evaluating any jaw lesion and/or adjacent enlarged lymph nodes by cytologic examination.
  • Adequate sampling is paramount to accurate diagnosis, and is especially important when attempting to distinguish ameloblastoma from ameloblastic carcinoma.
  • [MeSH-major] Ameloblastoma / diagnosis. Ameloblastoma / pathology. Mandibular Neoplasms / diagnosis. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19373909.001).
  • [ISSN] 1097-0339
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


62. Nagatsuka H, Han PP, Tsujigiwa H, Siar CH, Gunduz M, Sugahara T, Sasaki A, Nakajima M, Naomoto Y, Nagai N: Heparanase gene and protein expression in ameloblastoma: possible role in local invasion of tumor cells. Oral Oncol; 2005 May;41(5):542-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Heparanase gene and protein expression in ameloblastoma: possible role in local invasion of tumor cells.
  • Ameloblastoma is the most common odontogenic neoplasm, particularized by its local invasiveness.
  • In this study, we addressed to show the gene expression and localization of heparanase in ameloblastoma.
  • These results suggest the possible contribution of heparanase in the local invasiveness and secondary morphologic changes of ameloblastoma.
  • [MeSH-major] Ameloblastoma / enzymology. Glucuronidase / metabolism. Jaw Neoplasms / enzymology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15878761.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Messenger; EC 3.2.1.- / heparanase; EC 3.2.1.31 / Glucuronidase
  •  go-up   go-down


63. Migaldi M, Pecorari M, Rossi G, Maiorana A, Bettelli S, Tamassia MG, De Gaetani C, Leocata P, Portolani M: Does HPV play a role in the etiopathogenesis of ameloblastoma? An immunohistochemical, in situ hybridization and polymerase chain reaction study of 18 cases using laser capture microdissection. Mod Pathol; 2005 Feb;18(2):283-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Does HPV play a role in the etiopathogenesis of ameloblastoma? An immunohistochemical, in situ hybridization and polymerase chain reaction study of 18 cases using laser capture microdissection.
  • Among different etiologic factors, HPV infection has been recently postulated to be somehow involved in ameloblastoma etiopathogenesis.
  • In conclusion, our data do not support an etiopathogenetic evidence for HPV in ameloblastoma.
  • [MeSH-major] Ameloblastoma / pathology. Jaw Neoplasms / pathology. Papillomaviridae / genetics. Papillomavirus Infections / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15272281.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Oncogene Proteins, Viral
  •  go-up   go-down


64. Sukarawan W, Simmons D, Suggs C, Long K, Wright JT: WNT5A expression in ameloblastoma and its roles in regulating enamel epithelium tumorigenic behaviors. Am J Pathol; 2010 Jan;176(1):461-71
Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] WNT5A expression in ameloblastoma and its roles in regulating enamel epithelium tumorigenic behaviors.

  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 2000 Sep 15;275(37):29066-75 [10859305.001]
  • [Cites] Dev Biol. 2009 Feb 15;326(2):285-94 [19100728.001]
  • [Cites] Mech Dev. 2001 Sep;107(1-2):69-82 [11520664.001]
  • [Cites] Cancer Res. 2002 Jan 15;62(2):409-16 [11809689.001]
  • [Cites] Cancer Cell. 2002 Apr;1(3):279-88 [12086864.001]
  • [Cites] Nature. 2003 May 22;423(6938):448-52 [12717451.001]
  • [Cites] Cancer Sci. 2003 Jul;94(7):593-7 [12841867.001]
  • [Cites] Am J Clin Pathol. 2003 Nov;120(5):732-6 [14608900.001]
  • [Cites] Science. 2003 Dec 5;302(5651):1704-9 [14657486.001]
  • [Cites] Cancer Cell. 2003 Nov;4(5):349-60 [14667502.001]
  • [Cites] J Oral Pathol Med. 2004 Mar;33(3):147-55 [15128056.001]
  • [Cites] Int J Biochem Cell Biol. 2004 Oct;36(10):1890-909 [15203104.001]
  • [Cites] Int J Oral Maxillofac Surg. 2004 Sep;33(6):584-92 [15308259.001]
  • [Cites] Arch Oral Biol. 1992 Oct;37(10):771-8 [1444889.001]
  • [Cites] Cell Growth Differ. 1994 Feb;5(2):197-206 [8180133.001]
  • [Cites] Mol Cell Biol. 1994 Sep;14(9):6278-86 [8065359.001]
  • [Cites] Methods Enzymol. 1994;238:277-94 [7799794.001]
  • [Cites] Cancer Res. 1995 Aug 15;55(16):3495-9 [7627953.001]
  • [Cites] J Biol Chem. 1995 Dec 29;270(52):31225-34 [8537388.001]
  • [Cites] Arch Oral Biol. 1998 Nov;43(11):899-906 [9821513.001]
  • [Cites] J Bone Miner Res. 2005 Jun;20(6):1032-40 [15883644.001]
  • [Cites] J Biol Chem. 2005 Jun 17;280(24):23194-202 [15849362.001]
  • [Cites] J Oral Pathol Med. 2005 Aug;34(7):401-6 [16011608.001]
  • [Cites] Cancer Sci. 2005 Jul;96(7):379-86 [16053508.001]
  • [Cites] Cancer Res. 2005 Oct 15;65(20):9142-6 [16230369.001]
  • [Cites] J Clin Oncol. 2005 Dec 1;23(34):8765-73 [16314637.001]
  • [Cites] Methods. 2005 Oct;37(2):208-15 [16288884.001]
  • [Cites] Cancer Res. 2006 Mar 1;66(5):2815-25 [16510604.001]
  • [Cites] Oral Oncol. 2006 Apr;42(4):398-408 [16376138.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5454-9 [16569699.001]
  • [Cites] PLoS Biol. 2006 Apr;4(4):e115 [16602827.001]
  • [Cites] J Cell Biol. 2006 Nov 20;175(4):555-62 [17101698.001]
  • [Cites] Biochem J. 2007 Mar 15;402(3):515-23 [17117926.001]
  • [Cites] Oncogene. 2007 Oct 4;26(45):6560-5 [17486081.001]
  • [Cites] J Oral Pathol Med. 2007 Nov;36(10):609-14 [17944754.001]
  • [Cites] J Mol Med (Berl). 2008 Mar;86(3):259-66 [17952396.001]
  • [Cites] Dig Liver Dis. 2008 Jul;40(7):560-7 [18294932.001]
  • [Cites] J Bone Miner Res. 2008 Dec;23(12):1995-2006 [18665793.001]
  • [Cites] J Cell Sci. 2001 Jun;114(Pt 11):2043-53 [11493640.001]
  • (PMID = 20008136.001).
  • [ISSN] 1525-2191
  • [Journal-full-title] The American journal of pathology
  • [ISO-abbreviation] Am. J. Pathol.
  • [Language] ENG
  • [Grant] United States / NIDCR NIH HHS / DE / DE533921
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Proto-Oncogene Proteins; 0 / WNT5A protein, human; 0 / Wnt Proteins; 0 / Wnt5a protein, mouse
  • [Other-IDs] NLM/ PMC2797904
  •  go-up   go-down


65. Huang HZ, Zhang LT, Zeng DL, Zhang B: [The construction and expression of PcDNA3.1(+)/GFP-TIMP-2 in human ameloblastoma cell]. Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Dec;41(12):713-4
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The construction and expression of PcDNA3.1(+)/GFP-TIMP-2 in human ameloblastoma cell].
  • OBJECTIVE: To construct the eukaryotic expression vector of TIMP-2 gene and to explore its expression in human ameloblastoma cell in vitro.
  • After the PcDNA3.1(+)/GFP-TIMP-2 was transfected into cultured human ameloblastoma cell, RT-PCR and Flow Cytometry (FCM) and Microscope wre respectively performed to evaluate the effect of transfection and expression.
  • After PcDNA3.1(+)/GFP-TIMP-2 was trasnfected into cultured human ameloblastoma cell, the rate of transfection is 47.6% (Analysis report of FCM), the green fluorescence was found in plasm (observed with fluo-microwave), the expression of TIMP-2 mRNA was elevated 2.4 times compared with the control group.
  • CONCLUSIONS: PcDNA3.1(+)/GFP-TIMP-2 was successfully constructed and it could be transfected into cultured human ameloblastoma cell.
  • It may be benefit to further study of the relationship between the TIMP-2 gene and the behaviour of ameloblastoma.
  • [MeSH-major] Ameloblastoma / genetics. Genetic Vectors. Green Fluorescent Proteins / genetics. Jaw Neoplasms / genetics. Tissue Inhibitor of Metalloproteinase-2 / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17349188.001).
  • [ISSN] 1002-0098
  • [Journal-full-title] Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
  • [ISO-abbreviation] Zhonghua Kou Qiang Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / RNA, Messenger; 127497-59-0 / Tissue Inhibitor of Metalloproteinase-2; 147336-22-9 / Green Fluorescent Proteins
  •  go-up   go-down


66. Tao Q, Lü B, Qiao B, Zheng CQ, Chen ZF: [Characterization of growth and proliferation in a telomerase-immortalized ameloblastoma cell line]. Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Aug;44(8):474-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Characterization of growth and proliferation in a telomerase-immortalized ameloblastoma cell line].
  • OBJECTIVE: To establish and characterize the cell line of ameloblastoma (AM) by transfection with human telomerase reverse transcriptase (hTERT).
  • [MeSH-major] Ameloblastoma / genetics. Ameloblastoma / pathology. Cell Proliferation. Jaw Neoplasms / pathology. Telomerase / genetics. Transfection / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19961754.001).
  • [ISSN] 1002-0098
  • [Journal-full-title] Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
  • [ISO-abbreviation] Zhonghua Kou Qiang Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / Vimentin; 68238-35-7 / Keratins; EC 2.7.7.49 / TERT protein, human; EC 2.7.7.49 / Telomerase
  •  go-up   go-down


67. Bernaerts A, Vanhoenacker FM, Hintjens J, Chapelle K, De Schepper AM: Imaging approach for differential diagnosis of jaw lesions: a quick reference guide. JBR-BTR; 2006 Jan-Feb;89(1):43-6
MedlinePlus Health Information. consumer health - Jaw Injuries and Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Imaging approach for differential diagnosis of jaw lesions: a quick reference guide.
  • This article provides the reader a diagnostic approach pattern when confronted with an unknown jaw lesion.
  • Cardinal radiographic criteria include the density of the lesion and the location with regard to the adjacent tooth structures within the jaw.
  • Additional criteria in the evaluation of jaw lesions are demarcation, morphological characteristics, cortical involvement, periosteal and soft tissue changes.
  • [MeSH-major] Jaw Diseases / diagnosis. Jaw Neoplasms / diagnosis
  • [MeSH-minor] Ameloblastoma / diagnosis. Cementoma / diagnosis. Diagnosis, Differential. Fibrous Dysplasia of Bone / diagnosis. Humans. Magnetic Resonance Imaging. Nonodontogenic Cysts / diagnosis. Odontogenic Cysts / diagnosis. Odontogenic Tumors / diagnosis. Odontoma / diagnosis. Osteitis / diagnosis. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16607876.001).
  • [ISSN] 0302-7430
  • [Journal-full-title] JBR-BTR : organe de la Société royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR)
  • [ISO-abbreviation] JBR-BTR
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


68. Vered M, Peleg O, Taicher S, Buchner A: The immunoprofile of odontogenic keratocyst (keratocystic odontogenic tumor) that includes expression of PTCH, SMO, GLI-1 and bcl-2 is similar to ameloblastoma but different from odontogenic cysts. J Oral Pathol Med; 2009 Aug;38(7):597-604
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The immunoprofile of odontogenic keratocyst (keratocystic odontogenic tumor) that includes expression of PTCH, SMO, GLI-1 and bcl-2 is similar to ameloblastoma but different from odontogenic cysts.
  • [MeSH-major] Hedgehog Proteins / metabolism. Jaw Neoplasms / metabolism. Odontogenic Cysts / metabolism. Receptors, Cell Surface / metabolism. Receptors, G-Protein-Coupled / metabolism. Transcription Factors / metabolism
  • [MeSH-minor] Ameloblastoma / immunology. Ameloblastoma / metabolism. Ameloblastoma / pathology. Analysis of Variance. Basal Cell Nevus Syndrome / immunology. Basal Cell Nevus Syndrome / metabolism. Basal Cell Nevus Syndrome / pathology. Case-Control Studies. Gene Expression Regulation, Neoplastic / physiology. Humans. Immunohistochemistry. Jaw Diseases / immunology. Jaw Diseases / metabolism. Jaw Diseases / pathology. Proto-Oncogene Proteins c-bcl-2 / genetics. Proto-Oncogene Proteins c-bcl-2 / metabolism. Reference Values. Second Messenger Systems / physiology. Signal Transduction / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19473442.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / GLI1 protein, human; 0 / Hedgehog Proteins; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / Receptors, Cell Surface; 0 / Receptors, G-Protein-Coupled; 0 / SMO protein, human; 0 / Transcription Factors; 0 / patched receptors
  •  go-up   go-down


69. Sham E, Leong J, Maher R, Schenberg M, Leung M, Mansour AK: Mandibular ameloblastoma: clinical experience and literature review. ANZ J Surg; 2009 Oct;79(10):739-44

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mandibular ameloblastoma: clinical experience and literature review.
  • BACKGROUND: Ameloblastoma is a locally aggressive odontogenic tumour of the mandible and maxilla that, if neglected, can cause severe facial disfigurement and functional impairment.
  • Currently, wide resection and immediate reconstruction is the treatment of choice in most cases of mandibular ameloblastoma.
  • METHOD: Retrospective review of all patients between 1996 and 2006 with histologically confirmed ameloblastoma.
  • Two tumours involved the angle and posterior body of the mandible, one the angle and ramus, one the body and two the anterior mandibular.
  • Four patients underwent mandibular reconstruction with free tissue transfer and two by non-vascularized bone grafts.
  • Another developed a collection at the mandibular surgical site requiring drainage.
  • CONCLUSION: Management of ameloblastoma remains a challenge and requires a thorough understanding of the behaviour of its different clinicopathological variants.
  • [MeSH-major] Ameloblastoma. Mandibular Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19878171.001).
  • [ISSN] 1445-2197
  • [Journal-full-title] ANZ journal of surgery
  • [ISO-abbreviation] ANZ J Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Australia
  • [Number-of-references] 42
  •  go-up   go-down


70. Usami Y, Ito A, Ohnuma K, Fuku T, Komori T, Yokozaki H: Tumor suppressor in lung cancer-1 as a novel ameloblast adhesion molecule and its downregulation in ameloblastoma. Pathol Int; 2007 Feb;57(2):68-75
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumor suppressor in lung cancer-1 as a novel ameloblast adhesion molecule and its downregulation in ameloblastoma.
  • [MeSH-major] Ameloblastoma / metabolism. Down-Regulation / physiology. Immunoglobulins / metabolism. Jaw Neoplasms / metabolism. Membrane Proteins / metabolism. Tumor Suppressor Proteins / metabolism

  • Genetic Alliance. consumer health - Lung Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17300670.001).
  • [ISSN] 1320-5463
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Actins; 0 / CADM1 protein, human; 0 / Cadherins; 0 / Cell Adhesion Molecules; 0 / Immunoglobulins; 0 / Membrane Proteins; 0 / Tumor Suppressor Proteins; 0 / cell adhesion molecule 1, mouse
  •  go-up   go-down


71. Adeline VL, Dimba EA, Wakoli KA, Njiru AK, Awange DO, Onyango JF, Chindia ML: Clinicopathologic features of ameloblastoma in Kenya: a 10-year audit. J Craniofac Surg; 2008 Nov;19(6):1589-93

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathologic features of ameloblastoma in Kenya: a 10-year audit.
  • [MeSH-major] Ameloblastoma / epidemiology. Jaw Neoplasms / epidemiology. Medical Audit
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Aged, 80 and over. Child. Edema / epidemiology. Female. Humans. Kenya / epidemiology. Male. Mandibular Neoplasms / epidemiology. Maxillary Neoplasms / epidemiology. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Pain / epidemiology. Paresthesia / epidemiology. Retrospective Studies. Sex Factors. Suppuration. Time Factors. Tooth Mobility / epidemiology. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19098557.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


72. Torres-Lagares D, Infante-Cossío P, Hernández-Guisado JM, Gutiérrez-Pérez JL: Mandibular ameloblastoma. A review of the literature and presentation of six cases. Med Oral Patol Oral Cir Bucal; 2005 May-Jul;10(3):231-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mandibular ameloblastoma. A review of the literature and presentation of six cases.
  • Ameloblastoma is a benign odontogenic tumour of epithelial origin without induction in the connective tissue.
  • Articles have recently been published with the purpose of providing updated knowledge and therapeutic approaches to ameloblastoma.
  • We present six cases of patients with localised mandibular ameloblastoma who were treated during the last seven years.
  • We present data on clinical appearance, histological characteristics, and therapeutic approach that was used, which included excision of the lesion, perilesional drilling of the bone, or block resection, according to the type of ameloblastoma.
  • The aim of this paper is to review the concepts relating to ameloblastoma that have been published recently and to assess their influence on the clinical attitude taken when facing this pathology, using our experience with ameloblastoma as a starting point to illustrate this discussion.
  • [MeSH-major] Ameloblastoma / pathology. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15876966.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng; spa
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 33
  •  go-up   go-down


73. Lu L, Yang J, Liu JB, Yu Q, Xu Q: Ultrasonographic evaluation of mandibular ameloblastoma: a preliminary observation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Aug;108(2):e32-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ultrasonographic evaluation of mandibular ameloblastoma: a preliminary observation.
  • OBJECTIVE: The purpose of this study was to demonstrate ultrasonographic characteristics of mandibular ameloblastoma and assess the value of ultrasonography in diagnosis of the tumor.
  • CONCLUSION: Ultrasonography can be used as an effective supplementary diagnostic method for mandibular ameloblastomas.
  • [MeSH-major] Ameloblastoma / ultrasonography. Mandibular Neoplasms / ultrasonography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19615642.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


74. Tamme T, Tiigimäe J, Leibur E: Mandibular ameloblastoma: a 28-years retrospective study of the surgical treatment results. Minerva Stomatol; 2010 Nov-Dec;59(11-12):637-43

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mandibular ameloblastoma: a 28-years retrospective study of the surgical treatment results.
  • AIM: The aim of this study was to analyse the long-term treatment results of mandibular ameloblastomas over a 28-year period and determine the most appropriate method of management of these tumours.
  • METHODS: Sixteen patients with a diagnosis of mandibular ameloblastoma treated in our Department between January 1977 and December 2004 were selected for this retrospective study.
  • CONCLUSION: In summary, conservative treatment enucleation should be used only in the treatment of unicystic ameloblastoma, while the radical approach, resection with some safe margin, should be the first choice in the treatment of solid, multicystic mandibular ameloblastoma to avoid recurrence.
  • [MeSH-major] Ameloblastoma / surgery. Mandibular Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21217628.001).
  • [ISSN] 0026-4970
  • [Journal-full-title] Minerva stomatologica
  • [ISO-abbreviation] Minerva Stomatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


75. Zhao YF, Liu B, Jiang ZQ: [Marsupialization or decompression of the cystic lesions of the jaws]. Shanghai Kou Qiang Yi Xue; 2005 Aug;14(4):325-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Large odontogenic keratocyst or unicystic ameloblastoma is marsupialized initially and then enucleated at a later stage, reducing the possibility of pathological fracture of the mandible or the need for jaw resection.
  • [MeSH-minor] Ameloblastoma / surgery. Humans. Jaw / pathology. Jaw Neoplasms / surgery. Neoplasm Recurrence, Local / surgery. Odontogenic Tumors / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16155689.001).
  • [ISSN] 1006-7248
  • [Journal-full-title] Shanghai kou qiang yi xue = Shanghai journal of stomatology
  • [ISO-abbreviation] Shanghai Kou Qiang Yi Xue
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


76. Ladeinde AL, Ajayi OF, Ogunlewe MO, Adeyemo WL, Arotiba GT, Bamgbose BO, Akinwande JA: Odontogenic tumors: a review of 319 cases in a Nigerian teaching hospital. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Feb;99(2):191-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Odontogenic tumors constituted 9.6% of all the biopsies of oral and jaw lesions seen within the period under study.
  • Three hundred and eight (96.6%) were intraosseous, and 11 (3.4%) were peripheral (peripheral odontogenic fibroma=7; peripheral myxoma=3; peripheral ameloblastoma=1).
  • Ameloblastoma with predilection for the mandible was the most frequent odontogenic tumor (63%), followed by adenomatoid odontogenic tumor (AOT) (7.5%), myxoma (6.5%), calcifying epithelial odontogenic cyst (5.3%), and odontogenic fibroma (5.3%).
  • The mean ages of patients with AOT, ameloblastic fibroma, and odontoma were significantly lower than those with ameloblastoma ( P<.05).
  • CONCLUSIONS: Odontogenic tumors, especially ameloblastoma, are not considered rare among Nigerians, whereas odontoma, regarded as the most frequent odontogenic tumor in North and South America, is rare.
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Aged, 80 and over. Ameloblastoma / epidemiology. Child. Child, Preschool. Female. Hospitals, Teaching / statistics & numerical data. Humans. Jaw Neoplasms / epidemiology. Male. Mandibular Neoplasms / epidemiology. Middle Aged. Myxoma / epidemiology. Nigeria / epidemiology. Odontogenic Cyst, Calcifying / epidemiology. Odontoma / epidemiology. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15660091.001).
  • [ISSN] 1079-2104
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


77. Aregbesola SB, Ugboko VI, Akinwande JA, Arole GF, Fagade OO: Orofacial tumours in suburban Nigerian children and adolescents. Br J Oral Maxillofac Surg; 2005 Jun;43(3):226-31
MedlinePlus Health Information. consumer health - Oral Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of the latter 31 were from soft tissue and 41 were from the jaw (20 odontogenic and 21 non-odontogenic).
  • The most common benign soft tissue and jaw tumours were gingival epulis and ameloblastoma respectively.
  • [MeSH-minor] Adolescent. Adult. Age Factors. Ameloblastoma / epidemiology. Burkitt Lymphoma / epidemiology. Carcinoma / epidemiology. Child. Child, Preschool. Female. Fibrous Dysplasia of Bone / epidemiology. Gingival Diseases / epidemiology. Hemangioma / epidemiology. Humans. Infant. Infant, Newborn. Jaw Diseases / epidemiology. Jaw Neoplasms / epidemiology. Male. Nigeria / epidemiology. Odontogenic Tumors / epidemiology. Retrospective Studies. Sarcoma / epidemiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15888358.001).
  • [ISSN] 0266-4356
  • [Journal-full-title] The British journal of oral & maxillofacial surgery
  • [ISO-abbreviation] Br J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


78. Ledesma-Montes C, Mosqueda-Taylor A, Carlos-Bregni R, de León ER, Palma-Guzmán JM, Páez-Valencia C, Meneses-García A: Ameloblastomas: a regional Latin-American multicentric study. Oral Dis; 2007 May;13(3):303-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIM: To classify 163 ameloblastoma cases according to the new WHO Classification of Odontogenic Tumours (2005) and analyse their clinical and microscopic features.
  • METHODS: We studied the clinico-pathological features of 163 ameloblastoma cases from nine regional Latin-American institutions from Mexico and Guatemala.
  • The mean age was 41.4 years for solid ameloblastoma (SA) and 26.3 years for unicystic ameloblastoma (UA) (P < 0.001) and both sexes were almost equally affected.
  • CONCLUSIONS: In this study we found that UA was frequently misdiagnosed as SA; however, there are enough clinical and microscopic features that allow for an accurate differentiation between both types of ameloblastoma that should be recognized for surgical and prognostic purposes.
  • [MeSH-major] Ameloblastoma / classification. Ameloblastoma / pathology. Jaw Neoplasms / classification. Jaw Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17448213.001).
  • [ISSN] 1354-523X
  • [Journal-full-title] Oral diseases
  • [ISO-abbreviation] Oral Dis
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] Denmark
  •  go-up   go-down


79. Jundt G, Reichart PA: [Malignant odontogenic tumors]. Pathologe; 2008 May;29(3):205-13

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Odontogenic carcinomas comprise ameloblastic carcinoma (AmCa), primary intraosseous carcinoma (PIOC), clear cell odontogenic carcinoma, odontogenic ghost cell carcinoma (OGCC), and the special case of metastasizing ameloblastoma.
  • Whereas metastasizing ameloblastoma can be diagnosed only after having metastasized, all other malignant odontogenic tumors present with atypia, increased cellularity and mitoses, and invasion.
  • [MeSH-major] Jaw Neoplasms / pathology. Odontogenic Tumors / pathology
  • [MeSH-minor] Ameloblastoma / classification. Ameloblastoma / pathology. Carcinoma / classification. Carcinoma / pathology. Carcinosarcoma / classification. Carcinosarcoma / pathology. Diagnosis, Differential. Humans. Jaw / pathology. Neoplasm Invasiveness. Sarcoma / classification. Sarcoma / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Craniomaxillofac Surg. 2005 Oct;33(5):352-5 [16129612.001]
  • [Cites] J Dent Res. 2003 Jul;82(7):551-7 [12821718.001]
  • [Cites] Dentomaxillofac Radiol. 2004 May;33(3):152-7 [15371314.001]
  • [Cites] Int J Oral Maxillofac Surg. 2007 Jan;36(1):20-5 [17156974.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1994;30B(2):126-31 [7913362.001]
  • [Cites] Pathol Res Pract. 1979 Dec;166(1):123-30 [551398.001]
  • [Cites] J Oral Pathol Med. 1998 Feb;27(2):59-63 [9526730.001]
  • [Cites] Int J Oral Maxillofac Surg. 2001 Aug;30(4):349-55 [11518362.001]
  • [Cites] J Oral Pathol Med. 2005 May;34(5):318-20 [15817077.001]
  • [Cites] J Craniofac Surg. 2003 May;14(3):356-62 [12826807.001]
  • [Cites] Dtsch Z Mund Kiefer Gesichtschir. 1991 Mar-Apr;15(2):90-3 [1816940.001]
  • [Cites] Pathol Res Pract. 1983 Aug;178(1):40-7 [6227872.001]
  • [Cites] Hua Xi Yi Ke Da Xue Xue Bao. 1998 Dec;29(4):390-3 [10743235.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jun;103(6):799-807 [17448710.001]
  • [Cites] Rev Stomatol Chir Maxillofac. 2003 Oct;104(5):265-73 [14679345.001]
  • [Cites] Pathol Res Pract. 1985 Nov;180(5):526-35 [4080638.001]
  • [Cites] J Oral Maxillofac Surg. 2003 May;61(5):580-6 [12730837.001]
  • [Cites] J Oral Maxillofac Surg. 2007 Apr;65(4):777-83 [17368379.001]
  • [Cites] J Oral Maxillofac Surg. 2003 Feb;61(2):256-8 [12619007.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jul;104(1):72-5 [17577546.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Apr;103(4):516-20 [17395065.001]
  • [Cites] J Oral Maxillofac Surg. 2007 Sep;65(9):1820-4 [17719405.001]
  • [Cites] Arch Pathol Lab Med. 1993 Nov;117(11):1126-31 [8239934.001]
  • [Cites] Mod Pathol. 2004 Sep;17 (9):1062-7 [15133474.001]
  • [Cites] Head Neck. 2005 Jun;27(6):536-42 [15772956.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Feb;101(2):194-200 [16448921.001]
  • [Cites] J Craniofac Surg. 2004 Mar;15(2):264-9 [15167247.001]
  • [Cites] Virchows Arch. 2001 Apr;438(4):412-7 [11355179.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1977 Mar;43(3):391-401 [265043.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1995 Jun;121(6):685-9 [7772324.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jan;103(1):72-6 [17178497.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Aug;88(2):170-6 [10468461.001]
  • [Cites] J Oral Pathol Med. 1989 Feb;18(2):113-8 [2746520.001]
  • [Cites] Med Oral. 2001 May-Jul;6(3):173-9 [11500634.001]
  • (PMID = 18392827.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Germany
  •  go-up   go-down


80. Reichart PA, Jundt G: [Benign epithelial odontogenic tumors]. Pathologe; 2008 May;29(3):175-6, 178-88

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The group of benign epithelial odontogenic tumors consists of the four member types of the ameloblastoma family (solid/multicystic, extraosseous/peripheral, desmoplastic, unicystic), squamous odontogenic tumors, calcifying odontogenic tumors, adenomatoid odontogenic tumors, and keratocystic odontogenic tumors, the former "keratocysts" that were recently reclassified by the World Health Organization and are now regarded as tumors.
  • The latter are by far the most frequent tumors in this group, followed by solid/multicystic ameloblastoma.
  • [MeSH-major] Jaw Neoplasms / pathology. Odontogenic Cyst, Calcifying / pathology. Odontogenic Tumor, Squamous / pathology. Odontoma / pathology
  • [MeSH-minor] Ameloblastoma / classification. Ameloblastoma / pathology. Ameloblastoma / surgery. Cementoma / classification. Cementoma / pathology. Cementoma / surgery. Diagnosis, Differential. Humans. Jaw / pathology. Jaw / surgery. Prognosis. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Oral Pathol Med. 1993 Sep;22(8):378-83 [8283404.001]
  • [Cites] Histopathology. 2005 Dec;47(6):582-6 [16324195.001]
  • [Cites] Cancer. 1981 Mar 15;47(6):1358-63 [7226059.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1975 Nov;40(5):616-30 [1059063.001]
  • [Cites] Oral Oncol. 1999 Jul;35(4):443-9 [10645414.001]
  • [Cites] Pathol Res Pract. 2001;197(11):735-42 [11770017.001]
  • [Cites] Oral Oncol. 2005 Sep;41(8):835-42 [15979930.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1976 Dec;42(6):753-65 [792760.001]
  • [Cites] J Lab Clin Med. 2003 Nov;142(5):348-55 [14647039.001]
  • [Cites] Oral Oncol. 2002 Jun;38(4):323-31 [12076694.001]
  • [Cites] Arch Pathol Lab Med. 2004 Mar;128(3):313-7 [14987156.001]
  • [Cites] J Oral Maxillofac Surg. 1986 May;44(5):361-5 [3457915.001]
  • [Cites] Cancer. 1984 Apr 15;53(8):1730-5 [6697311.001]
  • [Cites] Bull Tokyo Dent Coll. 2002 Feb;43(1):13-21 [12013821.001]
  • [Cites] J Oral Pathol Med. 2006 May;35(5):278-85 [16630291.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1987 Jun;63(6):688-97 [3295656.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1995 Mar;31B(2):86-99 [7633291.001]
  • [Cites] Oral Oncol. 2002 Jul;38(5):407-15 [12110333.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 May;99(5):598-602 [15829884.001]
  • [Cites] J Dent Res. 2002 Aug;81(8):525-30 [12147741.001]
  • [Cites] J Oral Pathol Med. 2007 Aug;36(7):383-93 [17617830.001]
  • [Cites] Oral Oncol. 2001 Jul;37(5):455-60 [11377234.001]
  • [Cites] Acta Pathol Microbiol Scand A. 1978 Sep;86A(5):337-49 [716895.001]
  • [Cites] Oral Oncol. 2000 Jan;36(1):17-26 [10889914.001]
  • [Cites] J Oral Pathol Med. 1992 Sep;21(8):348-52 [1403843.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1985 Dec;60(6):624-30 [3865134.001]
  • [Cites] J Oral Maxillofac Surg. 2007 Feb;65(2):362-3 [17236955.001]
  • [Cites] Mund Kiefer Gesichtschir. 2006 Jan;10(1):1-2 [16328532.001]
  • [Cites] J Oral Maxillofac Surg. 2001 Jul;59(7):720-5; discussion 726-7 [11429726.001]
  • [Cites] Mund Kiefer Gesichtschir. 2004 May;8(3):167-72 [15138854.001]
  • [Cites] J Oral Maxillofac Surg. 2007 Jun;65(6):1227-31 [17517311.001]
  • [Cites] Oral Oncol. 2002 Apr;38(3):219-26 [11978543.001]
  • [Cites] Oral Oncol. 2001 Jan;37(1):17-27 [11120479.001]
  • [Cites] Int J Oral Maxillofac Surg. 1999 Jun;28(3):216-23 [10355946.001]
  • [Cites] Oral Oncol. 1999 Mar;35(2):125-31 [10435145.001]
  • [Cites] Cancer. 1977 Nov;40(5):2278-85 [922668.001]
  • [Cites] J Clin Periodontol. 1996 Oct;23 (10 ):922-6 [8915020.001]
  • [Cites] Int J Oral Maxillofac Surg. 2001 Feb;30(1):14-25 [11289615.001]
  • [Cites] Eur J Radiol. 2005 Oct;56(1):25-30 [16168260.001]
  • [Cites] J Dent Res. 2000 Jun;79(6):1418-22 [10890722.001]
  • [Cites] Oral Dis. 2003 Jan;9(1):1-6 [12617250.001]
  • [Cites] Oral Oncol. 1998 Sep;34(5):317-25 [9861335.001]
  • (PMID = 18389236.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] Adenoameloblastoma
  •  go-up   go-down


81. de Medeiros AM, Nonaka CF, Galvão HC, de Souza LB, Freitas Rde A: Expression of extracellular matrix proteins in ameloblastomas and adenomatoid odontogenic tumors. Eur Arch Otorhinolaryngol; 2010 Feb;267(2):303-10
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Immunohistochemical technique was performed in 20 cases of ameloblastoma (16 solid and 4 desmoplastic) and in 10 cases of AOT.
  • Our results might suggest a less invasive behavior of desmoplastic ameloblastoma in comparison to solid ameloblastoma.
  • [MeSH-major] Adenomatoid Tumor / metabolism. Ameloblastoma / metabolism. Collagen Type I / biosynthesis. Fibronectins / biosynthesis. Jaw Neoplasms / metabolism. Odontogenic Tumors / metabolism. Tenascin / biosynthesis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Biochem Cell Biol. 2004 Jun;36(6):986-90 [15094113.001]
  • [Cites] Int J Biochem Cell Biol. 2005 May;37(5):1066-83 [15743679.001]
  • [Cites] Biochim Biophys Acta. 2000 Mar 27;1470(2):O9-20 [10722930.001]
  • [Cites] Virchows Arch. 2002 Aug;441(2):165-73 [12189507.001]
  • [Cites] Cancer Lett. 2006 Dec 8;244(2):143-63 [16632194.001]
  • [Cites] J Cell Sci. 2007 Jun 15;120(Pt 12):1955-8 [17550969.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6):649-53 [11402276.001]
  • [Cites] J Cell Biol. 1997 Jun 16;137(6):1445-57 [9182674.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Nov;104(5):666-75 [17150384.001]
  • [Cites] Histopathology. 2004 Jul;45(1):65-72 [15228445.001]
  • [Cites] Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;61(2):101-9 [1720587.001]
  • [Cites] Biochem Soc Trans. 2004 Feb;32(Pt 1):17-20 [14748704.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1995 Jul;31B(4):275-9 [7492926.001]
  • [Cites] J Oral Maxillofac Surg. 1984 Nov;42(11):735-40 [6593446.001]
  • [Cites] J Endod. 1997 Sep;23(9):565-8 [9587282.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1996 Sep;32B(5):328-32 [8944836.001]
  • [Cites] Virchows Arch. 2000 Apr;436(4):319-23 [10834533.001]
  • [Cites] J Oral Pathol Med. 2007 Nov;36(10 ):609-14 [17944754.001]
  • [Cites] Braz J Otorhinolaryngol. 2006 Sep-Oct;72(5):709-13 [17221066.001]
  • [Cites] Oral Oncol. 2000 Jul;36(4):365-72 [10899676.001]
  • [Cites] Oral Oncol. 2001 Jul;37(5):455-60 [11377234.001]
  • [Cites] J Oral Pathol Med. 2006 Mar;35(3):183-9 [16454815.001]
  • [Cites] Arch Oral Biol. 2003 Oct;48(10):709-16 [12971948.001]
  • [Cites] Int J Oral Maxillofac Surg. 2006 Aug;35(8):750-5 [16690252.001]
  • [Cites] J Oral Pathol Med. 2000 Nov;29(10):483-90 [11048964.001]
  • [Cites] Ann Diagn Pathol. 2007 Jun;11(3):199-205 [17498594.001]
  • [Cites] Curr Opin Cell Biol. 2006 Oct;18(5):463-71 [16919434.001]
  • [Cites] Eur J Cancer. 2002 Dec;38(18):2362-70 [12460779.001]
  • [Cites] J Oral Pathol Med. 2004 Jul;33(6):354-9 [15200484.001]
  • [Cites] Oral Oncol. 1999 Mar;35(2):125-31 [10435145.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1994 May;30B(3):191-5 [7522711.001]
  • [Cites] Int J Oral Maxillofac Surg. 2007 Aug;36(8):671-9 [17643963.001]
  • [Cites] Int J Surg Pathol. 2008 Jul;16(3):277-85 [18573784.001]
  • [Cites] J Clin Periodontol. 2007 Aug;34(8):691-708 [17590157.001]
  • (PMID = 19466441.001).
  • [ISSN] 1434-4726
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Collagen Type I; 0 / Extracellular Matrix Proteins; 0 / Fibronectins; 0 / Tenascin
  •  go-up   go-down


82. Ohtsuru M: Expression of parathyroid hormone-related protein in ameloblastomas. Tokai J Exp Clin Med; 2005 Dec;30(4):233-9
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The present study, therefore, sought to clarify the expression of PTHrP, parathyroid hormone (PTH) and PTH1R in ameloblastoma, using RT-PCR (N = 8), immunohistochemistry (N = 23) and ELISA (N = 11) techniques.
  • Expression of PTHrP was also seen in all of the 23 cases in ameloblastoma by immunohistochemistry.
  • PTH1R was observed on osteoblasts in bone around the tumor but no expression was observed on ameloblastoma cells in tumor parenchyma by immunohistochemistry.
  • PTH was not detected in ameloblastoma by RT-PCR, immunohistochemistory as well as ELISA.
  • It was suggested that PTHrP level may be associated with local bone infiltration and hypercalcemia in ameloblastoma.
  • [MeSH-major] Ameloblastoma / genetics. Ameloblastoma / metabolism. Jaw Neoplasms / genetics. Jaw Neoplasms / metabolism. Parathyroid Hormone-Related Protein / genetics. Parathyroid Hormone-Related Protein / metabolism

  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16482944.001).
  • [ISSN] 0385-0005
  • [Journal-full-title] The Tokai journal of experimental and clinical medicine
  • [ISO-abbreviation] Tokai J. Exp. Clin. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / PTH1R protein, human; 0 / Parathyroid Hormone; 0 / Parathyroid Hormone-Related Protein; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / Receptor, Parathyroid Hormone, Type 1; 0 / Receptors, Parathyroid Hormone; SY7Q814VUP / Calcium
  •  go-up   go-down


83. Wang YP, Liu BY: Expression of osteopontin and its receptors in ameloblastomas. Oral Oncol; 2009 Jun;45(6):538-42

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In addition, binding of OPN to ameloblastoma tumor cell membrane receptor CD44v6 can enhance tumor cell migration, invasion and spread.
  • Therefore, we suggest that the local aggressive behavior and high osteolytic ability of ameloblastomas in the jawbones can be explained by the high expression of OPN and CD44v6 in ameloblastoma cells and the high expression of integrin alpha(v) in osteoclasts.
  • [MeSH-major] Ameloblastoma / metabolism. Antigens, CD44 / metabolism. Integrin alphaV / metabolism. Jaw Neoplasms / metabolism. Neoplasm Proteins / metabolism. Osteopontin / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18804406.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD44; 0 / CD44v6 antigen; 0 / Integrin alphaV; 0 / Neoplasm Proteins; 106441-73-0 / Osteopontin
  •  go-up   go-down


84. Chaine A, Pitak-Arnnop P, Dhanuthai K, Ruhin-Poncet B, Bertrand JC, Bertolus C: A treatment algorithm for managing giant mandibular ameloblastoma: 5-year experiences in a Paris university hospital. Eur J Surg Oncol; 2009 Sep;35(9):999-1005

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A treatment algorithm for managing giant mandibular ameloblastoma: 5-year experiences in a Paris university hospital.
  • AIMS: To review our experiences with giant mandibular ameloblastoma (GMA) over a 5-year period, and to formulate a treatment algorithm for managing this tumour.
  • FINDINGS: Forty-four ameloblastoma patients were operated upon during this study period.
  • [MeSH-major] Ameloblastoma / surgery. Fibula / transplantation. Mandibular Neoplasms / surgery. Osteotomy / methods. Surgical Flaps

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19423268.001).
  • [ISSN] 1532-2157
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


85. Feng Y, Zhou YM, Hua CG, Tang XF, He DQ: Expression of Twist in different subtype of ameloblastomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Oct;108(4):565-70

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: The objective of this study was to investigate the pattern of Twist expression in a series of ameloblastomas, and to study the possible role of Twist in the bone destruction and local invasiveness of ameloblastoma variants.
  • CONCLUSIONS: Our results suggest that Twist expression might be associated with invasion in ameloblastoma variants, and stromal cells might play a regulatory role during tumor development.
  • [MeSH-major] Ameloblastoma / classification. Jaw Neoplasms / classification. Nuclear Proteins / analysis. Twist Transcription Factor / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19699120.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Nuclear Proteins; 0 / TWIST1 protein, human; 0 / Twist Transcription Factor
  •  go-up   go-down


86. Luo HY, Yu SF, Li TJ: Differential expression of apoptosis-related proteins in various cellular components of ameloblastomas. Int J Oral Maxillofac Surg; 2006 Aug;35(8):750-5
SciCrunch. HGNC: Data: Gene Annotation .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To evaluate the expression patterns of apoptosis-related proteins, including Fas, Fas-ligand (FasL), caspase-3 and Bcl-2, in various cellular components of ameloblastomas, 39 cases of ameloblastoma were examined using immunohistochemistry.
  • [MeSH-major] Ameloblastoma / chemistry. Caspases / analysis. Jaw Neoplasms / chemistry. Membrane Glycoproteins / analysis. Neoplasm Proteins / analysis. Proto-Oncogene Proteins c-bcl-2 / analysis. Receptors, Tumor Necrosis Factor / analysis. Tumor Necrosis Factors / analysis

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16690252.001).
  • [ISSN] 0901-5027
  • [Journal-full-title] International journal of oral and maxillofacial surgery
  • [ISO-abbreviation] Int J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Antigens, CD95; 0 / BCL2L15 protein, human; 0 / FAS protein, human; 0 / FASLG protein, human; 0 / Fas Ligand Protein; 0 / Membrane Glycoproteins; 0 / Neoplasm Proteins; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / Receptors, Tumor Necrosis Factor; 0 / Tumor Necrosis Factors; EC 3.4.22.- / CASP3 protein, human; EC 3.4.22.- / Caspase 3; EC 3.4.22.- / Caspases
  •  go-up   go-down


87. Alves Pereira KM, do Amaral BA, dos Santos BR, Galvão HC, Freitas Rde A, de Souza LB: Immunohistochemical expression of E-cadherin and beta-catenin in ameloblastomas and tooth germs. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar;109(3):425-31
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • STUDY DESIGN: Twenty-one ameloblastoma cases (16 solid and 5 unicystic tumors) and 5 tooth germs were submitted to the immunohistochemical detection of E-cadherin and beta-catenin.
  • [MeSH-major] Ameloblastoma / metabolism. Cadherins / metabolism. Jaw Neoplasms / metabolism. Neoplasm Proteins / metabolism. Tooth Germ / metabolism. beta Catenin / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Mosby, Inc. All rights reserved.
  • (PMID = 20219600.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cadherins; 0 / Neoplasm Proteins; 0 / beta Catenin
  •  go-up   go-down


88. Raitz R, Assunção Júnior JN, Correa L, Fenyo-Pereira M: Parameters in panoramic radiography for differentiation of radiolucent lesions. J Appl Oral Sci; 2009 Sep-Oct;17(5):381-7
MedlinePlus Health Information. consumer health - Jaw Injuries and Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MATERIAL AND METHODS: In Part I, 12 specialists analyzed 24 images and the diagnostic criteria used by each examiner to make correct diagnoses were used to build a list of basic radiographic parameters for each pathology (ameloblastoma, keratocystic odontogenic tumor, dentigerous cyst, and idiopathic bone cavity).
  • [MeSH-major] Jaw Diseases / radiography. Radiography, Panoramic / statistics & numerical data
  • [MeSH-minor] Ameloblastoma / radiography. Dentigerous Cyst / radiography. Dentists. Diagnosis, Differential. Humans. Jaw Cysts / radiography. Jaw Neoplasms / radiography. Observer Variation. Odontogenic Tumors / radiography. Oral Medicine. Pathology, Oral. Probability. Radiology. Reproducibility of Results. Students, Dental. Surgery, Oral

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19936512.001).
  • [ISSN] 1678-7765
  • [Journal-full-title] Journal of applied oral science : revista FOB
  • [ISO-abbreviation] J Appl Oral Sci
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Brazil
  • [Other-IDs] NLM/ PMC4327660
  •  go-up   go-down


89. Yuan XP, Xie BK, Lin XF, Liang BL, Zhang F, Li JT: [Value of multi-slice spiral CT with three-dimensional reconstruction in the diagnosis of neoplastic lesions in the jawbones]. Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug;28(9):1700-2, 1706
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of these patients, 14 had ameloblastoma, 8 had hemangioma, 3 had osteosarcoma, 3 had ossifying fibroma, 2 had chondrosarcoma, 2 had fibrosarcoma, and 1 had odontogenic myxoma.
  • [MeSH-major] Imaging, Three-Dimensional / methods. Jaw / radiography. Jaw Neoplasms / diagnosis. Tomography, Spiral Computed / methods
  • [MeSH-minor] Adolescent. Adult. Ameloblastoma / diagnosis. Female. Hemangioma / diagnosis. Humans. Male. Middle Aged. Reproducibility of Results. Sensitivity and Specificity. Young Adult

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18819902.001).
  • [ISSN] 1673-4254
  • [Journal-full-title] Nan fang yi ke da xue xue bao = Journal of Southern Medical University
  • [ISO-abbreviation] Nan Fang Yi Ke Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


90. Niu CH, Li TJ: [Mutation and polymorphism of the ameloblastin gene in ameloblastomas]. Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Nov;41(11):678-81

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Genomic DNA was extracted from frozen tissues of 10 ameloblastomas and one malignant ameloblastoma.
  • [MeSH-major] Ameloblastoma / genetics. Dental Enamel Proteins / genetics. Jaw Neoplasms / genetics. Polymorphism, Genetic

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17331365.001).
  • [ISSN] 1002-0098
  • [Journal-full-title] Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
  • [ISO-abbreviation] Zhonghua Kou Qiang Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / AMBN protein, human; 0 / Dental Enamel Proteins
  •  go-up   go-down


91. Montoro JR, Tavares MG, Melo DH, Franco Rde L, Mello-Filho FV, Xavier SP, Trivellato AE, Lucas AS: Mandibular ameloblastoma treated by bone resection and immediate reconstruction. Braz J Otorhinolaryngol; 2008 Jan-Feb;74(1):155-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mandibular ameloblastoma treated by bone resection and immediate reconstruction.
  • Multicystic ameloblastoma mainly affects adult patients between the third and seventh decades of life, frequently in the posterior region of the mandible.
  • We present a 47-year-old male patient with an ameloblastoma in the posterior mandible who was treated with complete resection of a mandibular segment.
  • The advantages of this procedure include recurrence risk reduction due to segmental resection, reliable mandibular reconstruction and less surgical procedures, allowing full rehabilitation within a shorter period of time.
  • [MeSH-major] Ameloblastoma / surgery. Dental Implantation, Endosseous. Mandibular Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18392519.001).
  • [ISSN] 1808-8694
  • [Journal-full-title] Brazilian journal of otorhinolaryngology
  • [ISO-abbreviation] Braz J Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


92. Bologna-Molina R, Mosqueda-Taylor A, Lopez-Corella E, de Almeida OP, Carrasco-Daza D, Farfán-Morales JE, Molina-Frechero N, Damián-Matsumura P: Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma. Pathol Int; 2009 Apr;59(4):229-33
Genetic Alliance. consumer health - Ameloblastic carcinoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aims of the present study were to examine whether the pattern of syndecan-1 expression correlates with cellular proliferation index in desmoplastic ameloblastomas (DA), peripheral ameloblastomas (PA) and ameloblastic carcinomas (AC), and to compare with that previously reported for solid (SA) and unicystic (UA) variants of ameloblastoma.
  • [MeSH-major] Ameloblastoma / pathology. Carcinoma / pathology. Jaw Neoplasms / pathology. Ki-67 Antigen / biosynthesis. Syndecan-1 / biosynthesis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19351365.001).
  • [ISSN] 1440-1827
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / Syndecan-1
  •  go-up   go-down


93. Takenobu T, Nagano M, Taniike N, Furutani M, Tanaka Y: Mandibular reconstruction using intraoral trifocal bone transport: report of a case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 May;103(5):630-5
MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mandibular reconstruction using intraoral trifocal bone transport: report of a case.
  • On the mandibular reconstruction after tumor resection, it is easy to achieve esthetic and functional results when mandibular defect is relative small, however, it is difficult to reconstruct adequately larger defected mandible.
  • Recently, with progress of devices, distraction osteogenesis that is the method of tissue regeneration is used as mandibular reconstruction.
  • A 19-year-old male patient presented complaining of right lower jaw swelling.
  • Biopsy suspected a multiple-cystic ameloblastoma in mandible.
  • A mandibular reconstruction plate was attached to the proximal and distal bone segments.
  • The mandibular defect (85 mm) was reconstructed adequately using intraoral distraction osteogenesis trifocal bone transport technique.
  • [MeSH-major] Ameloblastoma / surgery. Mandible / surgery. Mandibular Neoplasms / surgery. Oral Surgical Procedures / methods. Osteogenesis, Distraction / methods. Reconstructive Surgical Procedures / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17466884.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


94. Asaumi J, Hisatomi M, Yanagi Y, Matsuzaki H, Choi YS, Kawai N, Konouchi H, Kishi K: Assessment of ameloblastomas using MRI and dynamic contrast-enhanced MRI. Eur J Radiol; 2005 Oct;56(1):25-30
Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There was no difference in the CI curve patterns among primary and recurrent cases, a case with glandular odontogenic tumor in ameloblastoma or among histopathological types such as plexiform, follicular, mixed, desmoplastic, and unicystic type.
  • [MeSH-major] Ameloblastoma / diagnosis. Gadolinium DTPA. Image Enhancement / methods. Jaw / pathology. Jaw Neoplasms / diagnosis. Magnetic Resonance Imaging / methods

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16168260.001).
  • [ISSN] 0720-048X
  • [Journal-full-title] European journal of radiology
  • [ISO-abbreviation] Eur J Radiol
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Contrast Media; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


95. Mareque Bueno J, Mareque Bueno S, Pamias Romero J, Bescos Atín MS, Huguet Redecilla P, Raspall Martín G: Mandibular ameloblastoma. Reconstruction with iliac crest graft and implants. Med Oral Patol Oral Cir Bucal; 2007 Jan;12(1):E73-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mandibular ameloblastoma. Reconstruction with iliac crest graft and implants.
  • The ameloblastoma is a bening odontogenic tumor.
  • [MeSH-major] Ameloblastoma / surgery. Bone Plates. Ilium / transplantation. Mandibular Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17195835.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 11
  •  go-up   go-down


96. Gyulai-Gaál S, Takács D, Barabás J, Tarján I, Martonffy K, Szabó G, Suba Z: [Mixed odontogenic tumors in children and adolescents]. Fogorv Sz; 2007 Apr;100(2):65-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Odontomas are calcifying benign hamartomas, and represent the most common type of odontogenic jaw tumors among patients less than 20y, having complex and compound variants.
  • Early diagnosis and treatment of mixed odontogenic jaw tumors in children may prevent the serious orthodontic complications and jaw deformations.
  • [MeSH-major] Jaw Neoplasms / diagnosis. Jaw Neoplasms / surgery. Odontogenic Tumors / diagnosis. Odontogenic Tumors / surgery. Tooth Eruption, Ectopic / etiology. Tooth, Impacted / etiology
  • [MeSH-minor] Adolescent. Ameloblastoma / diagnosis. Ameloblastoma / surgery. Child. Female. Hamartoma / diagnosis. Hamartoma / surgery. Humans. Male. Mandibular Neoplasms / diagnosis. Mandibular Neoplasms / surgery. Maxillary Neoplasms / diagnosis. Maxillary Neoplasms / surgery. Odontogenic Cysts / diagnosis. Odontogenic Cysts / surgery. Odontoma / diagnosis. Odontoma / surgery. Palatal Neoplasms / diagnosis. Palatal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17546897.001).
  • [ISSN] 0015-5314
  • [Journal-full-title] Fogorvosi szemle
  • [ISO-abbreviation] Fogorv Sz
  • [Language] hun
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Hungary
  •  go-up   go-down


97. Kumamoto H, Ooya K: Immunohistochemical detection of phosphorylated Akt, PI3K, and PTEN in ameloblastic tumors. Oral Dis; 2007 Sep;13(5):461-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Ameloblastoma / chemistry. Jaw Neoplasms / chemistry. Membrane Proteins / analysis. Oncogene Protein v-akt / analysis. PTEN Phosphohydrolase / analysis

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17714348.001).
  • [ISSN] 1354-523X
  • [Journal-full-title] Oral diseases
  • [ISO-abbreviation] Oral Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Membrane Proteins; EC 2.7.11.1 / Oncogene Protein v-akt; EC 3.1.3.48 / TPTE protein, human; EC 3.1.3.67 / PTEN Phosphohydrolase
  •  go-up   go-down


98. Simon EN, Merkx MA, Kalyanyama BM, Shubi FM, Stoelinga PJ: Evaluation of quality of life among patients after extirpation of mandibular ameloblastoma. East Afr Med J; 2005 Jun;82(6):314-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluation of quality of life among patients after extirpation of mandibular ameloblastoma.
  • OBJECTIVE: To evaluate the quality of life (QOL) based on the functional, aesthetic and personal satisfaction among patients with ameloblastoma who underwent either partial or total mandibulectomy without reconstruction.
  • SUBJECTS: Patients surgically treated for ameloblastoma without reconstruction.
  • [MeSH-major] Ameloblastoma / surgery. Mandibular Neoplasms / surgery. Oral Surgical Procedures / adverse effects. Patient Satisfaction. Quality of Life

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16175784.001).
  • [ISSN] 0012-835X
  • [Journal-full-title] East African medical journal
  • [ISO-abbreviation] East Afr Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Kenya
  •  go-up   go-down


99. Kitsoulis P, Charchanti A, Paraskevas G, Marini A, Karatzias G: Adamantinoma. Acta Orthop Belg; 2007 Aug;73(4):425-31
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma.
  • Adamantinoma is one of the rarest low-grade malignant bone tumours, representing less than 1% of them.
  • Fisher in 1913 named this tumour adamantinoma because of its similarity to ameloblastoma of the jaw.
  • Young males are more prone to develop adamantinoma than females.
  • [MeSH-major] Adamantinoma. Bone Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17939469.001).
  • [ISSN] 0001-6462
  • [Journal-full-title] Acta orthopaedica Belgica
  • [ISO-abbreviation] Acta Orthop Belg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Belgium
  • [Number-of-references] 58
  •  go-up   go-down


100. Poomsawat S, Punyasingh J, Vejchapipat P: Expression of basement membrane components in odontogenic tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Nov;104(5):666-75

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Ameloblastoma / pathology. Basement Membrane / pathology. Jaw Neoplasms / pathology. Odontogenic Cyst, Calcifying / pathology. Odontogenic Tumors / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17150384.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cell Adhesion Molecules; 0 / Collagen Type IV; 0 / Fibronectins; 0 / Laminin; 0 / kalinin; 0 / laminin 1
  •  go-up   go-down






Advertisement